Antihypertensive medication - note that there are other indications

RX_ANTIHYP

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — C0[789] 1 out of 7 registries used, show all original rules.	327810
4. Check minimum number of events Min. number of events 3	327810
5. Include endpoints None	327810
6. Filter based on genotype QC (FinnGen only)	294760

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	RX_ANTIHYP
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	C0[789]
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Antihypertensive medication - note that there are other indications based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2334599	1215225	1102476
Only index persons	2040159	1081643	958516
Unadjusted period prevalence (%)
Whole population	32.79	34.81	30.80
Only index persons	38.27	39.76	36.59
Median age at first event (years)
Whole population	57.85	58.94	56.51
Only index persons	56.16	57.07	55.14

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	294760	153620	141140
Unadjusted period prevalence (%)	59.41	54.54	64.72
Median age at first event (years)	54.56	52.90	56.37

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
41147: Matched controls
214908

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

369.9

322.6

421

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

322.3

4175

11235

A10AB01

ATC

insulin (human); parenteral

3.6

321.5

1347

1995

M01AE02

ATC

naproxen; oral, rectal

1.5

320.5

21708

91372

C02EA02, ,

ATC

16.3

318.0

420

136

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

317.8

5615

16843

N02CD06

ATC

rimegepant; oral

12.7

317.4

465

193

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.1

317.4

1118

1446

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

317.0

2592

5723

A12BA01

ATC

potassium chloride; oral

10.9

313.6

495

239

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

311.7

3373

8445

137

Kela drug reimbursment

Uraemia requiring dialysis

102.7

310.7

293

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

309.4

2250

4683

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

116.9

309.0

289

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

8.2

308.4

577

371

C08CA02

ATC

felodipine; oral

48.6

307.7

1781

200

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

11.7

307.7

759

346

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

13.3

307.7

2212

916

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

6.7

307.7

2050

1680

G43.9

ICD-10 Finland

Migraine, unspecified

3.6

307.7

4150

6474

C08CA13

ATC

lercanidipine; oral

116.3

307.7

3468

170

C10AA01

ATC

simvastatin; oral

3.2

307.7

7952

14859

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

8.8

307.7

638

383

Z49.1

ICD-10 Finland

Extracorporeal dialysis

35.9

307.7

361

N02CC06

ATC

eletriptan; oral

4.6

307.7

2149

2566

N05AH02

ATC

clozapine; systemic

4.6

307.7

1000

1152

E66

ICD-10 Finland

Obesity

2.8

307.7

2398

4590

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

307.7

8215

21712

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

5.8

307.7

1486

1391

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

9.7

307.7

1238

685

C09AA04

ATC

perindopril; oral

46.8

307.7

963

110

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.8

307.7

8267

17483

N05CF02

ATC

zolpidem; oral

1.9

307.7

5764

16744

N02BF02

ATC

pregabalin; oral

2.7

307.7

2335

4625

M04AA01

ATC

allopurinol; systemic

3.4

307.7

2190

3460

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.2

307.7

1612

2673

3007

Kela drug reimbursment

Erenumab and fremanezumab

22.0

307.7

1118

272

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

207.2

307.7

393

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

9.8

307.7

741

401

A11CC03

ATC

alfacalcidol; systemic

10.0

307.7

678

359

TK800

NOMESCO Finland

Hemodialysis

14.1

307.7

613

230

N02BE01

ATC

paracetamol; systemic, rectal

2.3

307.7

34542

150223

205

Kela drug reimbursment

Chronic hypertension

33.5

307.7

5607

1006

I25.1

ICD-10 Finland

Atherosclerotic heart disease

6.9

307.7

3708

3037

N03AX12

ATC

[U] gabapentin; oral

2.5

307.7

4940

11149

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

4.2

307.7

2706

3541

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.5

307.7

2955

6339

C09DA03

ATC

valsartan and diuretics; oral

232.0

307.7

827

I25.2

ICD-10 Finland

Old myocardial infarction

16.9

307.7

879

278

C09DA06

ATC

candesartan and diuretics; oral

170.0

307.7

1924

N05BA12

ATC

alprazolam; oral

2.5

307.7

3041

6584

C03DA01

ATC

spironolactone; oral

5.2

307.7

2826

3003

N02CC05

ATC

almotriptan; oral

3.8

307.7

2084

2984

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

121.4

307.7

323

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.0

307.7

4412

8281

C09CA01

ATC

losartan; oral

39.2

307.7

8269

1369

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

307.7

3278

7094

M03BX02

ATC

tizanidine; oral

1.6

307.7

23306

95059

OAB50, ,

SPAT

3.0

307.7

2223

4068

E66.01

ICD-10 Finland

Obesity due to excess calories

3.0

307.7

4527

8548

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.9

307.7

6635

10017

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

12.7

307.7

2002

860

R00.2

ICD-10 Finland

Palpitations

2.8

307.7

3377

6763

G44.2

ICD-10 Finland

Tension-type headache

2.0

307.7

5570

15620

N05BA04

ATC

oxazepam; oral

2.3

307.7

10416

27135

N03AG01

ATC

valproic acid; systemic, rectal

2.8

307.7

2288

4451

TFP20

NOMESCO Finland

Cardiodefibrillation

16.1

307.7

1150

384

C07AB02

ATC

metoprolol; systemic

17.6

307.7

5938

2045

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

20.2

307.7

620

163

I25

ICD-10 Finland

Chronic ischaemic heart disease

17.2

307.7

543

167

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.8

307.7

7261

9172

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.4

307.7

2825

6325

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

307.7

5238

14002

C07AB12

ATC

nebivolol; oral

43.2

307.7

866

107

I47.1

ICD-10 Finland

Supraventricular tachycardia

4.2

307.7

1264

1607

G43

ICD-10 Finland

Migraine

3.4

307.7

3929

6385

N03AX11

ATC

topiramate; oral

7.5

307.7

1411

1016

C09AA03

ATC

lisinopril; oral

65.6

307.7

667

N06AX26

ATC

vortioxetine; oral

2.3

307.7

3951

9361

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.4

307.7

6046

10499

J01FF01

ATC

clindamycin; systemic

1.7

307.7

8618

29158

Z94.0

ICD-10 Finland

Kidney transplant status

95.9

307.7

508

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

3.1

307.7

1879

3271

A10BK01

ATC

dapagliflozin; oral

6.7

307.7

1885

1535

C09AA05

ATC

ramipril; oral

36.1

307.7

6377

1085

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

9.3

307.7

1479

856

C07AA05

ATC

propranolol; systemic

6.0

307.7

12482

14498

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

8.0

307.7

4328

3122

C08DB01

ATC

diltiazem; oral

22.7

307.7

667

156

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

5.4

307.7

4401

4636

207

Kela drug reimbursment

Chronic arrhythmias

26.8

307.7

2423

501

I50.1

ICD-10 Finland

Left ventricular failure

15.7

307.7

763

259

R53

ICD-10 Finland

Malaise and fatigue

1.7

307.7

9338

32238

103

Kela drug reimbursment

Diabetes, insulin-treated

4.5

307.7

7694

10403

C09DB01

ATC

valsartan and amlodipine; oral

68.6

307.7

773

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

307.7

14681

42046

C10AX09

ATC

ezetimibe; oral

4.3

307.7

3954

5206

G43.3

ICD-10 Finland

Complicated migraine

10.0

307.7

1298

699

N05AH04

ATC

quetiapine; oral

2.6

307.7

8813

20551

C09BA02

ATC

enalapril and diuretics; systemic

191.9

307.7

1316

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

8.6

307.7

993

613

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

11.7

307.7

951

432

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

20.5

307.7

451

116

T82

ICPC

Obesity

3.3

307.7

1890

3054

N18.8

ICD-10 Finland

Other chronic renal failure

23.3

307.7

506

115

C01AA05

ATC

digoxin; systemic

5.6

307.7

1077

1024

C09CA08

ATC

olmesartan medoxomil; oral

107.3

307.7

326

G47.3

ICD-10 Finland

Sleep apnoea

2.8

307.7

7914

16940

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

28.8

307.7

599

110

C09AA02

ATC

enalapril; systemic

41.4

307.7

5169

743

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

8.7

307.7

1047

642

C03AA03

ATC

hydrochlorothiazide; oral

12.9

307.7

1426

598

I49.3

ICD-10 Finland

Ventricular premature depolarization

3.5

307.7

2042

3140

C01BC04

ATC

flecainide; systemic

22.9

307.7

613

142

N06AB10

ATC

escitalopram; oral

2.0

307.7

9812

29304

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

11.8

307.7

711

320

C07BB07

ATC

bisoprolol and thiazides; systemic

311.0

307.7

587

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.5

307.7

2039

3159

C08CA05

ATC

nifedipine; systemic

6.7

307.7

1487

1194

N02CC03

ATC

zolmitriptan; nasal, oral

3.4

307.7

2601

4148

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

307.7

7242

22842

B01AA03

ATC

warfarin; systemic

3.9

307.7

3208

4510

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.7

8055

26380

H3603, E103,

ICD-10 Finland

14.0

307.7

502

189

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

4.4

307.7

2647

3324

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

307.7

2667

5813

E66.8

ICD-10 Finland

Other obesity

3.5

307.7

2482

3821

K86

ICPC

Hypertension uncomplicated

28.9

307.7

2919

567

N02CC04

ATC

rizatriptan; oral

3.2

307.7

2776

4820

J01AA02

ATC

doxycycline; systemic

1.7

307.7

27227

115880

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

307.7

6535

17751

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

24.2

307.7

930

205

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

11.1

307.7

754

362

C08DA01

ATC

verapamil; systemic

16.9

307.7

1129

358

N03AX09

ATC

lamotrigine; oral

3.3

307.7

2737

4482

N02CD02

ATC

galcanezumab; parenteral

31.0

307.7

359

TFP34

NOMESCO Finland

Electrophysiological investigation

6.1

307.7

831

725

K85

ICPC

Elevated blood pressure

7.9

307.7

4551

3340

C03CA01

ATC

furosemide; systemic

4.8

307.7

6227

7754

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

12.5

307.7

2845

1273

N02CD01

ATC

erenumab; parenteral

26.2

307.7

637

129

C07AA07

ATC

sotalol; systemic

18.1

307.7

498

145

A10BK03

ATC

empagliflozin; oral

6.7

307.7

2461

2024

C07AB03

ATC

atenolol; systemic

17.0

307.7

932

292

A10AC01

ATC

insulin (human); parenteral

3.3

307.7

2424

3949

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

163.7

307.7

342

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

9.5

307.7

1760

1005

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

307.7

6194

18200

T89

ICPC

Diabetes insulin dependent

3.2

307.7

1672

2769

I20.09

ICD-10 Finland

Unstable angina

8.3

307.7

780

499

E66.00

ICD-10 Finland

Metabolic syndrome

5.7

307.7

1810

1721

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

10.5

307.7

970

494

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

307.7

3260

7148

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.7

307.7

4403

9033

N06AX11

ATC

mirtazapine; oral

2.1

307.7

13212

39438

XF400

NOMESCO Finland

ECG with 12 standard connections

2.5

307.7

4052

8847

R42

ICD-10 Finland

Dizziness and giddiness

1.9

307.7

6613

20026

127

Kela drug reimbursment

Transplant complication

17.1

307.7

683

212

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

307.7

2658

5211

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.0

307.7

4205

7752

L04AD02

ATC

tacrolimus; systemic

25.4

307.7

547

114

C10AA05

ATC

atorvastatin; oral

3.2

307.7

10504

20856

I50.0

ICD-10 Finland

Congestive heart failure

10.0

307.7

918

490

Angiography of the heart and coronary arteries

15.0

307.7

641

226

A10BJ02

ATC

liraglutide; parenteral

10.4

307.7

857

439

I48

ICD-10 Finland

Atrial fibrillation and flutter

7.5

307.7

3394

2562

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

9.8

307.7

1045

570

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

307.7

6245

17669

N06AX12

ATC

bupropion; oral

2.5

307.7

4138

9274

N05AX12

ATC

aripiprazole; systemic

3.3

307.7

2577

4298

J01DB01

ATC

cefalexin; oral

1.8

307.7

32226

144112

B01AF02

ATC

apixaban; oral

4.3

307.7

2047

2613

R5140

NOMESCO Finland

Monitoring the use of the aid

2.8

307.7

3047

5985

C09CA07

ATC

telmisartan; oral

37.5

307.7

1835

267

C07AB07

ATC

bisoprolol; oral

18.9

307.7

18409

8836

N06AB06

ATC

sertraline; oral

2.3

307.7

5336

13223

R06.0

ICD-10 Finland

Dyspnoea

2.2

307.7

8197

22081

N05CF01

ATC

zopiclone; oral

2.0

307.7

9808

28638

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

9.3

307.7

1637

958

C01DA14

ATC

isosorbide mononitrate; oral

9.2

307.7

2174

1302

C10AA07

ATC

rosuvastatin; oral

2.5

307.7

9428

22826

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

13.5

307.7

862

339

I20.99

ICD-10 Finland

Angina pectoris, unspecified

6.5

307.7

866

710

A10AE05

ATC

insulin detemir; parenteral

3.7

307.7

1653

2403

I50.9

ICD-10 Finland

Heart failure, unspecified

8.9

307.7

2070

1276

201

Kela drug reimbursment

Chronic cardiac insufficiency

7.7

307.7

1106

768

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

307.7

11064

34650

C07AG02

ATC

carvedilol; oral

44.1

307.7

1022

124

C09CA03

ATC

valsartan; oral

52.2

307.7

2198

232

N89

ICPC

Migraine

3.7

307.7

2826

4197

XF404

NOMESCO Finland

Ambulatory ECG

4.5

307.7

2258

2712

C09BB04

ATC

perindopril and amlodipine; systemic

95.9

307.7

328

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

57.7

307.7

642

K80

ICPC

Cardiac arrhythmia NOS

3.4

307.7

2478

4033

I48.1

ICD-10 Finland

Persistent atrial fibrillation

14.7

307.7

451

162

AA1AD

NOMESCO Finland

CT of head and brain

2.3

307.7

7549

19488

C09DA01

ATC

losartan and diuretics; oral

187.2

307.7

2524

N05AH03

ATC

olanzapine; systemic

2.9

307.7

3092

5862

M54.5

ICD-10 Finland

Low back pain

1.6

307.7

13665

51229

B01AC04

ATC

clopidogrel; oral

5.5

307.7

2656

2666

C08CA01

ATC

amlodipine; oral

46.2

307.7

12143

1931

SPAT1262

SPAT

Handing over of treatment supplies

2.9

307.7

4554

8850

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.8

307.7

1829

2628

M79.6

ICD-10 Finland

Pain in limb

1.6

307.7

15654

59630

A10AB05

ATC

insulin aspart; parenteral

3.6

307.7

2485

3790

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

29.9

307.7

448

SPAT1097

SPAT

Recording of ECG

2.6

307.7

3222

6771

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

307.7

14431

54660

N06AX21

ATC

duloxetine; oral

2.8

307.7

4757

9642

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.5

307.7

5720

13074

N02BF01

ATC

gabapentin; oral

2.4

307.7

3289

7462

I42.0

ICD-10 Finland

Dilated cardiomyopathy

27.6

307.7

465

N06AB03

ATC

fluoxetine; oral

2.1

307.7

4232

11110

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

307.7

14962

53401

A10BA02

ATC

metformin; oral

4.2

307.7

8066

11810

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

33.6

307.7

584

A10BJ06

ATC

semaglutide; parenteral

9.3

307.7

1633

952

N02AX02

ATC

tramadol; systemic, rectal

1.9

307.7

13890

44777

N02CC07

ATC

frovatriptan; oral

4.6

307.7

2507

2962

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

307.7

2060

3562

C02AC05

ATC

moxonidine; oral

260.2

307.7

830

N05BA01

ATC

diazepam; systemic, rectal

2.5

307.7

4016

8901

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

31.0

307.7

498

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.8

307.7

4327

6519

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.7

307.7

3743

4510

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

50.6

307.7

460

XF402

NOMESCO Finland

ECG with work load test

3.8

307.7

2134

3039

N05AX08

ATC

risperidone; systemic

2.4

307.7

2770

6189

I10

ICD-10 Finland

Essential (primary) hypertension

33.8

307.7

22085

7130

I48.2

ICD-10 Finland

Chronic atrial fibrillation

23.3

307.7

467

106

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

44.9

307.7

501

R51.80

ICD-10 Finland

Headache

2.1

307.7

7247

20005

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

307.7

6715

19578

A10BH01

ATC

sitagliptin; oral

5.1

307.7

1774

1884

A10BB12

ATC

glimepiride; oral

5.6

307.7

833

786

N03AX16

ATC

[U] pregabalin

2.3

307.7

7051

17849

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

35.4

307.7

640

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

307.7

7522

24238

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

307.7

2286

4319

L04AA06

ATC

mycophenolic acid; systemic

10.3

307.7

801

412

T90

ICPC

Diabetes non-insulin dependent

4.7

307.7

6215

7871

N06AX16

ATC

venlafaxine; oral

2.6

307.7

6718

15149

A02BC03

ATC

lansoprazole; oral

1.8

307.7

7538

24337

H02AB06

ATC

prednisolone; systemic

1.8

307.7

16011

56652

A02BC02

ATC

pantoprazole; systemic

2.1

307.7

24606

88344

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

4.9

307.7

5907

7077

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.3

307.7

1623

2643

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

4.1

307.7

4758

6715

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

307.7

16044

56502

N02CD03

ATC

fremanezumab; systemic

20.9

307.7

778

198

C09CA06

ATC

candesartan; oral

24.7

307.7

12662

3798

B01AC24

ATC

ticagrelor; oral

22.8

307.7

602

140

A02BC05

ATC

esomeprazole; systemic

1.7

307.7

12880

45328

C09DA07

ATC

telmisartan and diuretics; oral

158.2

307.7

773

WX872

NOMESCO Finland

Intensive care

4.5

307.7

1056

1261

A10AE04

ATC

insulin glargine; parenteral

4.2

307.7

2881

3781

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

39.7

307.7

718

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

307.7

8347

24706

N06AB04

ATC

citalopram; systemic

2.2

307.7

7190

19173

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

9.8

307.7

814

441

AN1

Coronary angiography

11.1

307.7

1448

702

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.5

307.7

3646

8128

C01BD01

ATC

amiodarone; systemic

57.7

307.7

394

Z3231

NOMESCO Finland

Registered nurse

1.7

307.7

8727

28783

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

28.9

307.7

443

K78

ICPC

Atrial fibrillation/flutter

8.7

307.7

916

564

R03AC02

ATC

salbutamol; inhalant

1.7

307.7

21190

82881

I47.2

ICD-10 Finland

Ventricular tachycardia

14.0

307.5

431

162

R02

ICPC

Shortness of breath/dyspnoea

2.0

305.8

3952

10614

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.0

303.8

1656

2927

A12AA04

ATC

calcium carbonate; oral

15.7

303.6

407

137

M10.9

ICD-10 Finland

Gout, unspecified

4.0

303.5

1122

1509

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.9

303.3

1803

3357

A10BH05

ATC

linagliptin; oral

6.5

302.6

674

549

G43.8

ICD-10 Finland

Other migraine

4.7

302.6

914

1032

A10AB04

ATC

insulin lispro; parenteral

3.7

301.7

1208

1729

S18

ICPC

Laceration/cut

1.5

300.2

14403

56072

A10AE06

ATC

insulin degludec; parenteral

3.6

299.9

1244

1828

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

298.9

4450

12578

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.5

298.6

1304

1989

N06AA09

ATC

amitriptyline; systemic

2.6

297.0

2117

4358

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

104.8

296.3

279

P06

ICPC

Sleep disturbance

1.9

295.8

5242

15710

XCK10

NOMESCO Finland

Photography of fundus of eye

2.6

294.7

2159

4508

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

292.0

6167

19506

C03BA11

ATC

indapamide; oral

21.1

291.7

353

C09BA05

ATC

ramipril and diuretics; oral

118.7

290.0

271

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

289.5

10271

37270

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

288.5

6464

20794

C09BA04

ATC

perindopril and diuretics; systemic

139.3

286.1

265

K04

ICPC

Palpitations/awareness of heart

2.8

284.5

1737

3283

M01AB05

ATC

diclofenac; systemic, rectal

1.5

283.2

22779

98181

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

283.1

7456

25075

AN4

Balloon angioplasty and drug eluding stent

22.0

282.6

338

A10BJ05

ATC

dulaglutide; parenteral

11.1

282.1

441

209

L28

ICPC

Limited function/disability (L)

2.0

280.8

4079

11415

N05BE01

ATC

buspirone; oral

3.9

280.8

1053

1432

SPAT1263

SPAT

Sampling

1.5

280.4

14629

57745

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

280.0

7728

26305

N05AA02

ATC

levomepromazine; systemic

3.3

277.7

1331

2164

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

277.7

7155

23905

I20.01

ICD-10 Finland

Unstable angina

21.6

277.2

333

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

276.9

8762

30868

WX892

NOMESCO Finland

Monitored bed care

2.7

276.8

1879

3766

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.4

275.4

2252

4964

A28

ICPC

Limited function/disability NOS

2.1

275.0

3082

7813

A46

ICD-10 Finland

Erysipelas

2.1

273.1

3361

8841

250, ,

Kela drug reimbursment

76.8

272.6

263

K87

ICPC

Hypertension complicated

32.9

271.0

294

R4110

NOMESCO Finland

Physiotherapy

1.6

270.8

8121

28207

160

Kela drug reimbursment

exenatide

17.0

269.9

351

109

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

84.7

269.7

258

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.7

269.1

1809

3606

A02BC01

ATC

omeprazole; systemic

1.6

268.9

7849

27068

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

265.0

5570

17547

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

264.9

4410

12916

C07AB05

ATC

betaxolol; oral

27.3

262.0

296

E66.9

ICD-10 Finland

Obesity, unspecified

3.1

260.9

1398

2442

N03AE01

ATC

clonazepam; systemic

2.8

260.6

1648

3175

M01AH05

ATC

etoricoxib; oral

1.4

260.3

21958

94804

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.9

259.4

1544

2873

N06AX22

ATC

agomelatine; oral

3.4

259.3

1196

1894

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

8.7

258.8

467

284

SPAT1310

SPAT

Counselling related to known health issue

1.5

258.2

10518

39208

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.5

258.0

1956

4150

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

257.9

7844

27296

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.1

257.9

719

751

R60.0

ICD-10 Finland

Localized oedema

2.1

257.8

2932

7469

C10AA04

ATC

fluvastatin; oral

3.6

257.6

1099

1647

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

256.8

2690

6625

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

255.7

10118

37456

Z2446

NOMESCO Finland

Social worker

2.3

254.0

2470

5891

N19

ICD-10 Finland

Unspecified kidney failure

6.7

253.1

551

436

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

251.8

28296

128667

B01AB05

ATC

enoxaparin; parenteral

1.6

251.5

7960

27949

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

250.7

3892

11122

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

2.7

250.6

1629

3186

ZXD05

NOMESCO Finland

Urgent procedure

1.5

250.5

9868

36464

ZY010

NOMESCO Finland

Hospital outpatient

2.3

249.6

2461

5904

H03AA01

ATC

levothyroxine sodium; systemic

1.7

249.2

6808

23027

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

249.1

6169

20326

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

247.5

2370

5612

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

22.4

247.3

294

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

246.9

7695

26902

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

14.0

246.8

346

130

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.5

246.1

1051

1576

P01AB01

ATC

metronidazole; oral, rectal

1.5

246.0

13530

53600

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.1

245.5

3028

7958

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

245.1

4915

15240

P76

ICPC

Depressive disorder

2.0

245.0

3276

8876

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

243.8

1701

3456

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

3.8

243.5

961

1359

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

4.4

242.9

782

935

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

242.9

6753

22928

C07AB08

ATC

celiprolol; oral

35.0

242.7

260

3051, ,

Kela drug reimbursment

9.1

242.6

426

248

A10BD07

ATC

metformin and sitagliptin; systemic

4.9

241.6

700

759

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

240.4

11512

44292

N06AB05

ATC

paroxetine; oral

2.4

240.0

2048

4600

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

8.4

239.2

439

274

C07FB02

ATC

metoprolol and felodipine; systemic

329.0

238.9

313

N07BB01

ATC

disulfiram; oral

2.8

237.7

1456

2753

J01FA06

ATC

roxithromycin; oral

1.5

237.3

12166

47439

L17

ICPC

Foot/toe symptom/complaint

1.5

236.8

9757

36335

J01DA01

ATC

[U] cefalexin

1.4

236.4

21452

93130

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

236.2

3247

8881

WX780

NOMESCO Finland

Remote monitoring CPAP

2.9

236.0

1347

2444

A01

ICPC

Pain general/multiple sites

2.0

234.4

3016

8050

F40.1

ICD-10 Finland

Social phobias

2.8

233.5

1494

2895

Z49.0

ICD-10 Finland

Preparatory care for dialysis

63.3

232.9

229

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

231.4

20612

89037

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

231.4

13533

54095

J01MA02

ATC

ciprofloxacin; systemic

1.5

231.3

10852

41508

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

231.0

10190

38473

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

7.4

230.8

463

329

N18.0

ICD-10 Finland

End-stage renal disease

34.3

230.5

248

M25.5

ICD-10 Finland

Pain in joint

1.5

230.5

11686

45405

A10AA02, ,

ATC

3.5

230.1

986

1482

P74

ICPC

Anxiety disorder/anxiety state

2.2

229.5

2522

6326

UJF32

NOMESCO Finland

Coloscopy

1.6

229.1

6382

21643

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

7.0

228.8

481

364

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.2

228.7

1111

1821

N06AX05

ATC

trazodone; oral

3.7

228.2

922

1327

B01AC06

ATC

acetylsalicylic acid; oral

15.1

228.2

310

108

SPAT1240

SPAT

Therapeutic discussion

1.7

227.8

4885

15424

H02AB04

ATC

methylprednisolone; systemic

1.8

227.7

3962

11738

R11

ICD-10 Finland

Nausea and vomiting

2.0

226.5

3178

8751

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

10.3

226.1

368

188

A10AA01, ,

ATC

3.7

224.9

910

1311

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.4

223.9

1930

4353

L03

ICPC

Low back symptom/complaint

1.5

222.5

10408

39723

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

222.4

19882

85688

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

221.4

7684

27467

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

220.3

220.7

294

K84

ICPC

Heart disease other

8.4

219.8

406

256

XF602

NOMESCO Finland

Bloodpressure monitoring

10.2

219.3

358

184

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

218.7

3450

9890

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

13.6

218.4

310

120

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

218.1

2274

5578

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

217.8

7429

26437

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

216.6

10382

39779

Z71.8

ICD-10 Finland

Other specified counselling

1.4

216.1

13111

52598

WX002

NOMESCO Finland

Sedation and analgesia

1.7

216.0

4759

15128

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.8

215.5

833

1159

SPAT1100

SPAT

Long-term monitoring of blood pressure

3.4

214.6

968

1508

R01AD09

ATC

mometasone; nasal

1.4

214.4

17146

72290

N05AF03

ATC

chlorprothixene; systemic

3.5

213.3

922

1394

P29

ICPC

Psychological sympt/compl other

1.8

213.2

3996

12104

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

13.5

212.9

303

118

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

211.7

1766

3920

I35.0

ICD-10 Finland

Aortic (valve) stenosis

4.5

210.2

671

796

SPAT1301

SPAT

No procedures

1.5

210.0

9563

36216

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

209.8

3674

10892

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

208.8

2731

7323

N02CC02

ATC

naratriptan; oral

4.3

208.6

687

838

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.4

206.5

1722

3821

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

93.5

206.5

196

V03AE01

ATC

polystyrene sulfonate; oral

15.6

205.8

276

WX402

NOMESCO Finland

General anaesthesia

1.5

205.4

7484

26992

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

14.2

205.2

286

106

M79.1

ICD-10 Finland

Myalgia

1.6

205.2

5576

18739

C10AA03

ATC

pravastatin; oral

3.3

203.9

967

1559

P99

ICPC

Psychological disorders other

2.6

203.6

1494

3112

P01

ICPC

Feeling anxious/nervous/tense

1.6

203.6

7243

25976

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

11.8

203.4

308

137

J01MA12

ATC

levofloxacin; systemic

1.7

203.4

4470

14181

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

202.5

15222

63283

E87.6

ICD-10 Finland

Hypokalaemia

4.1

202.3

718

933

WX723

NOMESCO Finland

CPAP therapy

2.8

201.1

1273

2450

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.7

200.8

796

1129

I50

ICD-10 Finland

Heart failure

15.8

200.0

267

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.4

199.5

1702

3816

C07AG01

ATC

labetalol; systemic

10.8

199.5

317

155

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

199.3

1477

3092

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

4.4

199.2

653

793

Z3226

NOMESCO Finland

Physiotherapist

1.7

199.2

5045

16635

A11

ICPC

Chest pain NOS

2.2

198.5

2046

4990

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.7

197.7

1358

2732

TFP35

NOMESCO Finland

Electroanatomical mapping

9.8

197.6

331

178

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

197.2

2637

7123

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

196.9

2297

5891

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

10.9

196.9

310

149

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

196.7

3013

8538

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

196.3

17377

74159

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

195.7

2025

4946

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

194.4

2374

6197

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

14.5

194.2

268

WZC30

NOMESCO Finland

Teaching

1.7

193.6

4392

14047

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.6

193.5

5718

19600

R50.9

ICD-10 Finland

Fever, unspecified

1.6

193.2

5179

17320

AN3

Balloon angioplasty and metallic stent

18.5

192.8

243

R07.3

ICD-10 Finland

Other chest pain

1.9

192.6

2847

7968

C09BA03

ATC

lisinopril and diuretics; oral

330.6

192.4

252

B03XA02

ATC

darbepoetin alfa; parenteral

6.1

192.2

450

389

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

192.0

5833

20126

H36.01

ICD-10 Finland

Diabetic maculopathy

6.8

191.8

410

317

SPAT1260

SPAT

Consultation of another employee

1.6

191.8

5118

17094

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

4.5

191.0

597

695

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

32.8

189.8

206

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

46.3

189.7

194

WX290

NOMESCO Finland

Other blockage of nerve

1.4

189.4

20240

88889

B01AF01

ATC

rivaroxaban; oral

2.2

188.4

2037

5065

I49.1

ICD-10 Finland

Atrial premature depolarization

3.4

188.1

866

1368

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

5.9

188.0

452

403

M79.7

ICD-10 Finland

Fibromyalgia

2.8

187.9

1179

2257

R03DC03

ATC

montelukast; oral

1.6

187.8

5602

19232

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

186.9

8188

30645

N05AN01

ATC

lithium; oral

3.1

186.8

964

1642

SPAT1252

SPAT

Overall medication plan or its review

2.7

186.6

1233

2429

I20.00

ICD-10 Finland

Unstable angina

9.8

186.1

312

168

K76

ICPC

Ischaemic heart dis without angina

15.5

184.6

248

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

184.5

3933

12348

H04AA01

ATC

glucagon; nasal, parenteral

2.8

184.3

1121

2108

S97

ICPC

Chronic ulcer skin

2.8

184.2

1113

2085

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

184.2

1154

2207

R06AE07

ATC

cetirizine; oral

1.4

184.2

16305

69334

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

184.2

3322

9921

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

183.5

1673

3865

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

183.5

1926

4730

B05DA

ATC

Isotonic solutions

213.0

182.9

244

K25

ICPC

Fear of hypertension

3.4

182.6

810

1247

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

182.4

2986

8644

M01AC06

ATC

meloxicam; systemic, rectal

1.5

182.1

9643

37443

Single vessel balloon catheter extension

48.5

182.1

185

N02CD07, ,

ATC

28.8

182.0

203

SPAT1153

SPAT

Removal of sutures

1.5

181.7

7956

29747

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

90.2

180.7

172

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

5.5

179.5

461

442

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.1

179.2

635

824

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

3.1

178.3

908

1533

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

3.0

178.2

1005

1808

I20.90

ICD-10 Finland

Angina pectoris, unspecified

7.1

177.9

370

276

N06AX03

ATC

mianserin; oral

2.7

177.9

1155

2253

Z49.2

ICD-10 Finland

Other dialysis

158.3

176.9

240

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.5

176.9

1307

2730

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

176.0

6933

25331

SPAT1254

SPAT

Administration of medicine

1.7

176.0

4258

13837

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.0

175.9

985

1764

C08CA10

ATC

nilvadipine; oral

302.9

175.9

231

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

37.5

175.8

186

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

12.6

175.2

257

107

R01AD58

ATC

fluticasone, combinations; nasal

1.4

173.7

10346

40998

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

173.6

9714

38053

G44.0

ICD-10 Finland

Cluster headache syndrome

5.2

172.7

470

479

K05

ICPC

Irregular heartbeat other

3.7

172.5

698

1005

WX722

NOMESCO Finland

PEEP

3.2

172.3

865

1447

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

172.2

1666

3950

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

172.1

3174

9535

D07AC01

ATC

betamethasone; topical

1.4

171.2

11317

45660

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

171.2

10651

42516

P03

ICPC

Feeling depressed

1.6

171.1

5040

17216

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.9

171.1

496

538

N01

ICPC

Headache

1.6

170.5

5484

19131

H03BB01

ATC

carbimazole; oral

2.6

169.5

1196

2439

F41.00

ICD-10 Finland

Moderate panic disorder

3.3

169.4

786

1248

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

168.9

7437

27782

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.2

168.7

816

1332

H3601, E103,

ICD-10 Finland

6.0

168.6

402

355

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

12.2

168.5

251

108

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

168.3

1813

4497

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.8

167.5

653

914

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

3.1

167.5

850

1432

I49.5

ICD-10 Finland

Sick sinus syndrome

5.8

166.4

407

370

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.0

166.2

604

800

SFA30

NOMESCO Finland

Three-surface restoration

1.4

166.1

13752

57551

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.4

165.9

533

636

Coronary artery bypass surgery

35.7

165.9

177

L01

ICPC

Neck symptom/complaint

1.5

165.3

5823

20727

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

165.1

2273

6193

K77

ICPC

Heart failure

22.0

164.9

197

A02BA02

ATC

ranitidine; systemic

1.7

164.9

4103

13419

R03BB04

ATC

tiotropium bromide; inhalant

2.1

164.5

1833

4609

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.4

164.4

1401

3136

L04AD01

ATC

ciclosporin; systemic

3.9

164.3

610

822

B05DB

ATC

Hypertonic solutions

191.8

164.1

220

OAB93, ,

SPAT

1.8

163.9

3201

9778

K02.1

ICD-10 Finland

Caries of dentine

1.3

162.9

23876

108949

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

6.1

162.9

382

331

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

162.7

11247

45643

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

10.0

162.1

268

141

J01CA04

ATC

amoxicillin; systemic

1.4

161.9

32500

155886

N05AB03

ATC

perphenazine; systemic, rectal

2.7

161.2

1060

2081

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.4

161.2

421

411

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

161.1

3751

12045

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

12.4

160.8

238

101

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

160.5

28905

135982

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

160.4

8731

33940

A10AD01

ATC

insulin (human); parenteral

4.1

160.4

558

713

SPAT1255

SPAT

Intravenous administration of medicine

2.2

160.2

1561

3711

C02DE04, ,

ATC

16.3

160.1

211

A10BX07

ATC

[U] liraglutide

19.9

160.0

197

N05BA06

ATC

lorazepam; systemic, sublingual

2.5

159.9

1257

2707

R05

ICPC

Cough

1.4

159.8

8467

32747

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.6

159.7

1149

2366

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.5

158.3

1183

2484

P15

ICPC

Chronic alcohol abuse

2.7

158.1

1041

2045

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

9.4

156.7

269

151

A06AD11

ATC

lactulose; oral

1.8

156.6

3024

9201

N02AA05

ATC

oxycodone; systemic

1.7

156.3

3520

11195

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

156.3

1845

4745

R96

ICPC

Asthma

1.8

156.1

2763

8186

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.3

156.0

1472

3450

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

156.0

3441

10882

A10BG03

ATC

pioglitazone; oral

6.2

155.4

356

300

ZXE00

NOMESCO Finland

One hour or less

1.4

155.3

12162

50300

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

155.3

4234

14163

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.8

155.0

450

489

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

154.6

8496

33052

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

154.4

1968

5211

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

154.3

2960

8987

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

4.1

154.1

545

706

SGA01

NOMESCO Finland

Emergency treatment

1.5

153.8

6370

23444

M02AA07

ATC

piroxicam; topical

1.4

153.7

8657

33824

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.9

153.5

891

1630

Z2445

NOMESCO Finland

Psychologist

2.1

153.0

1731

4377

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

16.8

152.9

199

R03BA02

ATC

budesonide; inhalant

1.5

152.6

5742

20703

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.0

152.5

827

1452

ZXA00

NOMESCO Finland

Right side

1.5

151.8

5927

21538

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.0

151.7

2063

5592

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

151.7

2743

8178

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

18.8

151.6

190

M48.0

ICD-10 Finland

Spinal stenosis

2.0

151.4

1896

4986

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

64.6

150.9

148

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

150.4

2725

8128

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

150.2

2753

8241

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

4.0

150.2

545

721

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

9.2

150.2

260

148

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

148.6

2861

8693

F34.1

ICD-10 Finland

Dysthymia

2.3

148.3

1380

3214

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

148.2

1972

5303

R55

ICD-10 Finland

Syncope and collapse

1.8

148.1

2552

7492

J45

ICD-10 Finland

Asthma

1.7

148.1

3336

10603

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.9

148.0

2427

7013

N05CD07

ATC

temazepam; oral

2.0

147.8

2070

5669

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.3

147.1

691

1106

AA1

Conventional CABG

55.0

147.1

147

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

146.7

9405

37546

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.1

146.6

752

1275

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.9

146.3

868

1608

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

146.2

1493

3619

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

33.1

146.0

158

GD1LA

NOMESCO Finland

10.3

145.8

237

121

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

5.0

145.4

411

435

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.1

145.0

1565

3882

F61.0

ICD-10 Finland

Mixed personality disorders

3.2

143.7

703

1156

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

143.7

2442

7136

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

143.5

5848

21420

N06AA10

ATC

nortriptyline; systemic

3.7

143.0

581

839

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

7.2

143.0

291

211

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

12.5

142.8

210

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

142.6

11656

48385

SPAT1104

SPAT

Monitoring of emergency patient

2.2

142.5

1478

3606

SPAT1216

SPAT

Assessment of functional ability

1.7

142.2

2913

9010

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.1

142.1

725

1225

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

141.7

2830

8688

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

141.3

4004

13503

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

141.0

4141

14088

162

Kela drug reimbursment

liraglutide

18.3

140.8

178

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

140.7

1274

2930

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

14.3

140.0

194

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

140.0

941

1869

P72

ICPC

Schizophrenia

3.2

139.5

698

1165

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

139.5

5636

20594

R03BA05

ATC

fluticasone; inhalant

1.5

139.2

5954

22011

SPAT1081

SPAT

Cardiorespiratory global assessment

2.9

139.1

824

1525

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

3.0

138.9

763

1350

R4190

NOMESCO Finland

Nutritional therapy

2.2

138.8

1460

3582

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.4

138.7

1178

2631

R01AD12

ATC

fluticasone furoate; nasal

1.3

138.6

12351

51909

Z2221

NOMESCO Finland

Medical doctor

1.4

137.9

8493

33611

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

163.4

137.5

186

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

137.3

26294

123069

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.8

137.0

400

437

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

136.7

3162

10113

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

110.8

136.6

190

J02AC01

ATC

fluconazole; systemic

1.3

136.5

13502

57604

N06BA04

ATC

methylphenidate; oral

1.9

136.2

2108

5972

S10

ICPC

Boil/carbuncle

2.0

136.2

1857

5035

SFA20

NOMESCO Finland

Two-surface restoration

1.3

135.9

22391

102561

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

135.8

3479

11433

K04.0

ICD-10 Finland

Pulpitis

1.6

135.7

3696

12336

R4110, ,

SPAT

1.7

135.4

3282

10630

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

10.2

135.2

221

114

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

135.0

2368

6985

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

134.4

1316

3132

OAB42, ,

SPAT

1.6

134.4

4444

15534

C09AA01

ATC

captopril; oral

22.1

134.2

160

R04.0

ICD-10 Finland

Epistaxis

2.2

134.0

1421

3498

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

133.9

2792

8673

H3600, E103,

ICD-10 Finland

4.2

133.8

454

568

CKC12

NOMESCO Finland

Photocoagulation of retina

2.5

133.8

1051

2261

M10.0

ICD-10 Finland

Idiopathic gout

4.0

133.5

482

635

Catheterization and pressure measurement of the left side of the heart

12.1

133.4

199

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

62.4

133.0

131

R01AD08

ATC

fluticasone; nasal

1.4

133.0

9791

39883

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

29.6

132.7

147

I44.2

ICD-10 Finland

Atrioventricular block, complete

5.4

132.5

346

338

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

132.4

4110

14156

A04

ICPC

Weakness/tiredness general

1.5

132.0

5370

19628

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

40.2

132.0

138

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

131.9

1000

2114

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

131.7

4370

15282

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

5.1

131.3

362

374

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.3

131.1

604

954

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.8

130.5

795

1495

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

130.3

4145

14355

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.5

130.2

551

820

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.4

129.8

580

897

3025

Kela drug reimbursment

Calcium carbonate

22.9

129.6

153

M10

ICD-10 Finland

Gout

3.0

129.0

711

1261

B02AA02

ATC

tranexamic acid; systemic

1.5

128.9

4703

16792

SPAT1377

SPAT

Polysomnography

2.7

128.9

854

1683

EBA00

NOMESCO Finland

Extraction of tooth

1.3

128.4

13332

57144

J01FA09

ATC

clarithromycin; systemic

1.4

128.4

10095

41509

R52.2

ICD-10 Finland

Other chronic pain

2.4

128.2

1093

2445

UKC02

NOMESCO Finland

Cystoscopy

1.7

128.1

3011

9666

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.7

127.9

827

1608

SFA10

NOMESCO Finland

One-surface restoration

1.3

127.8

21152

96571

N17

ICPC

Vertigo/dizziness

1.6

127.8

3312

10908

ZX120

NOMESCO Finland

Intravenous

1.8

127.7

2388

7181

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

126.5

1592

4190

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

126.3

8142

32399

R03BA01

ATC

beclometasone; inhalant

1.6

126.1

3708

12598

A10BD20

ATC

metformin and empagliflozin; oral

6.8

126.1

268

206

E0000UV, ,

ATC

1.3

126.0

14434

62679

A08

ICPC

Swelling

2.4

126.0

1055

2340

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

125.6

4328

15254

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

125.4

3835

13151

WZC00, ,

SPAT

1.5

124.9

5032

18339

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

124.8

157

R52.9

ICD-10 Finland

Pain, unspecified

1.6

124.7

3214

10567

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.0

124.7

1548

4053

R51

ICD-10 Finland

Headache

1.8

124.4

2317

6958

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

124.4

22816

105408

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.0

124.1

695

1244

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

124.1

2282

6826

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

112.8

123.9

172

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

123.9

12635

53944

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

123.1

1919

5445

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.3

123.1

575

917

K07

ICPC

Swollen ankles/oedema

2.9

122.9

698

1260

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

122.9

2032

5878

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.3

122.4

574

918

A10BX04

ATC

[U] exenatide

17.5

122.4

157

C07AB04

ATC

acebutolol; systemic

22.3

122.0

145

K08.3

ICD-10 Finland

Retained dental root

1.9

122.0

1832

5133

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.9

121.9

712

1307

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.3

121.4

581

942

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.6

121.3

880

1819

AP1

Catheterization of the left side of the heart

17.7

121.2

155

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.7

121.2

816

1622

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

6.6

121.0

263

208

M03AX01

ATC

botulinum toxin; parenteral

3.0

120.9

652

1141

WZC30, ,

SPAT

1.8

120.3

2189

6525

ZY000

NOMESCO Finland

Hospital inpatient

3.1

120.1

606

1017

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.7

120.0

2752

8769

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

120.0

1657

4509

C08CA03

ATC

isradipine; systemic

61.8

119.7

118

B01AE07

ATC

dabigatran etexilate; oral

3.8

119.5

454

623

G25.0

ICD-10 Finland

Essential tremor

3.6

119.1

493

722

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

119.1

1583

4249

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.5

119.1

264

214

C09DX04

ATC

valsartan and sacubitril; oral

+∞

118.4

149

A10BJ01

ATC

exenatide; parenteral

13.0

118.3

171

D11

ICPC

Diarrhoea

1.5

118.1

4771

17382

OAB72, ,

SPAT

3.0

117.4

640

1127

J01FA10

ATC

azithromycin; systemic

1.3

117.1

22179

102495

A29

ICPC

General symptom/complaint other

1.6

117.1

3529

12050

H02AB09

ATC

hydrocortisone; systemic

2.6

116.4

791

1580

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.3

116.2

1087

2535

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

8.1

116.2

218

141

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

116.1

1164

2797

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.9

116.0

428

574

R80

ICD-10 Finland

Isolated proteinuria

7.0

115.9

241

180

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

115.6

1448

3802

TK820

NOMESCO Finland

Peritoneal dialysis

119.1

115.1

159

J01MA14

ATC

moxifloxacin; systemic

1.8

115.1

2104

6279

M01AH01

ATC

celecoxib; oral

1.5

114.8

3974

14002

OAA65, ,

SPAT

1.4

114.7

9094

37319

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

114.2

2789

9034

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.8

113.9

685

1279

N04BC05

ATC

pramipexole; oral

2.0

113.8

1515

4068

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.9

113.3

428

585

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.9

113.3

421

568

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

35.2

113.1

121

H3601, E113,

ICD-10 Finland

11.1

113.0

176

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

112.8

2122

6386

P19

ICPC

Drug abuse

3.2

112.7

544

887

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2.7

112.6

745

1467

N06AA12

ATC

doxepin; systemic

2.4

112.1

956

2138

ACC51

NOMESCO Finland

Release of median nerve

1.8

111.8

1886

5487

L08

ICPC

Shoulder symptom/complaint

1.4

111.8

6454

25133

R06.5

ICD-10 Finland

Mouth breathing

1.7

111.7

2559

8146

E87.5

ICD-10 Finland

Hyperkalaemia

6.6

111.4

243

193

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

111.2

140

SPAT1283

SPAT

Restricted health certificate

1.4

111.2

8484

34582

L86

ICPC

Back syndrome with radiating pain

1.9

111.1

1627

4517

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

111.1

2395

7498

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

110.7

11636

49701

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

9.2

110.5

192

110

F32

ICD-10 Finland

Depressive episode

1.7

110.5

2267

6997

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.6

110.5

461

679

ZXA05

NOMESCO Finland

Left side

1.4

109.9

5338

20141

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

5.6

109.7

278

263

J01EA01

ATC

trimethoprim; systemic

1.4

109.6

7393

29542

K29

ICPC

Cardiovascular sympt/complt other

2.9

109.1

640

1178

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

109.0

10097

42347

N06AG02

ATC

moclobemide; oral

2.3

109.0

963

2189

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

13.1

108.9

157

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.3

108.9

981

2249

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.9

108.9

1616

4507

F41.01

ICD-10 Finland

Severe panic disorder

4.7

108.6

327

368

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

108.3

1364

3588

V03AE02

ATC

sevelamer; oral

112.3

108.1

150

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.1

107.7

565

972

K04.08

ICD-10 Finland

Other specified pulpit

1.6

107.4

3214

10945

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

2.4

107.0

857

1860

N07BA03

ATC

varenicline; oral

1.9

107.0

1547

4276

R03AC03

ATC

terbutaline; inhalant

1.5

106.8

4059

14578

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

106.8

3156

10714

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

106.8

1618

4544

ZXA10

NOMESCO Finland

Bilateral

1.5

106.8

4296

15614

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

106.7

9295

38616

SPAT1058

SPAT

PEF monitoring instruction

1.8

106.6

1896

5607

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

105.9

3347

11542

K30

ICD-10 Finland

Functional dyspepsia

1.5

105.9

3470

12066

J20

ICD-10 Finland

Acute bronchitis

1.6

105.7

3193

10895

XF640, ,

NOMESCO Finland

4.1

105.7

371

478

C02EA03, ,

ATC

36.7

105.5

112

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

3.1

105.3

530

888

G04CA02

ATC

tamsulosin; oral

1.5

105.3

3720

13152

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

105.2

2237

6974

M01AX17

ATC

nimesulide; oral

1.5

105.1

4775

17776

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.6

104.8

3066

10382

P18

ICPC

Medication abuse

4.9

104.7

299

320

I34.1

ICD-10 Finland

Mitral (valve) prolapse

3.4

104.6

462

709

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.9

104.3

583

1043

N30.0

ICD-10 Finland

Acute cystitis

1.4

104.2

5314

20213

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

28.9

104.2

116

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

104.2

4046

14594

CKC15

NOMESCO Finland

Panretinal photocoagulation

9.1

104.1

181

104

PD5AD

NOMESCO Finland

CT of aorta

4.0

103.9

379

504

A10BH02

ATC

vildagliptin; oral

7.0

103.7

215

160

PA6AD

NOMESCO Finland

CT of neck arteries

2.5

103.6

789

1671

EB1VA, ,

NOMESCO Finland

1.4

103.5

6046

23556

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

103.5

1574

4425

H02AB07

ATC

prednisone; oral

1.6

103.5

3189

10930

H05BX01

ATC

cinacalcet; oral

18.1

103.2

131

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

103.2

2196

6846

IGV01

NOMESCO Finland

Psychiatric network contact

2.9

103.0

586

1059

F10.24

ICD-10 Finland

Alcohol depence active use

3.4

102.9

460

712

XFE00

NOMESCO Finland

Epicardial ultrasonography

4.0

102.5

371

490

R5110, ,

SPAT

1.9

102.5

1559

4383

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.9

102.2

571

1021

196

Kela drug reimbursment

Paricalcitol and cinacalcet

146.1

102.1

139

A99

ICPC

Disease/condition unspecnature/site

1.6

102.1

2840

9497

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.3

102.1

340

419

J01CF05

ATC

flucloxacillin; systemic

1.7

101.9

2192

6854

SPAT1312

SPAT

General health counselling

1.3

101.7

10911

46615

A02BC04

ATC

rabeprazole; oral

1.7

101.6

2401

7701

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

16.9

101.6

132

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

101.3

1890

5670

C08CA07

ATC

nisoldipine; oral

42.3

101.3

105

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

101.1

3028

10306

L15

ICPC

Knee symptom/complaint

1.4

100.9

7314

29512

SPAT1229

SPAT

Assessment of need for aid

2.0

100.8

1233

3207

XG466

NOMESCO Finland

Sleep oxymetry

2.9

100.7

579

1053

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

100.6

2246

7095

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

100.5

3495

12306

R06AX27

ATC

desloratadine; oral

1.3

100.5

11197

48062

C07BB02

ATC

metoprolol and thiazides; systemic

231.7

100.3

133

K22

ICPC

Risk factor cardiovascular disease

2.3

100.1

921

2132

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.6

100.1

691

1392

A03

ICPC

Fever

1.4

100.0

7323

29590

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

99.7

2223

7018

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.1

99.7

512

869

N04AA02

ATC

biperiden; systemic

3.0

99.7

532

925

M54.2

ICD-10 Finland

Cervicalgia

1.6

99.5

2449

7939

R31

ICD-10 Finland

Unspecified haematuria

1.8

99.3

1840

5508

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

99.2

1050

2580

B03XA01

ATC

erythropoietin; parenteral

8.4

99.1

182

114

I20.91

ICD-10 Finland

Angina pectoris, unspecified

24.1

98.8

115

E26.0

ICD-10 Finland

Primary hyperaldosteronism

24.1

98.8

115

U14

ICPC

Kidney symptom/complaint

4.7

98.3

294

329

CL2S4, ,

SPAT

3.1

98.1

498

839

R4120

NOMESCO Finland

Occupational therapy

1.8

97.8

1671

4878

R03BA08

ATC

ciclesonide; inhalant

1.6

97.7

2422

7865

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

97.4

2420

7862

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

97.2

757

1621

I15.8

ICD-10 Finland

Other secondary hypertension

16.9

97.1

126

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

96.9

35462

176017

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.0

96.9

1183

3075

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.2

96.6

966

2318

R05

ICD-10 Finland

Cough

1.4

96.6

6451

25672

KBV00

NOMESCO Finland

Insertion of stent into ureter

7.0

96.4

200

149

G43.2

ICD-10 Finland

Status migrainosus

7.7

96.4

187

127

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

10.7

96.3

153

TK810

NOMESCO Finland

Hemofiltration

13.9

96.2

135

C10AB05

ATC

fenofibrate; oral

4.5

96.2

304

358

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

96.0

1472

4149

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

95.9

1521

4335

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

95.8

1856

5629

C09CA02

ATC

eprosartan; oral

221.2

95.6

127

SPAT1234

SPAT

Support of social functional capacity

2.2

95.5

995

2429

4019X

ICD-9 Finland

Essential hypertension, Unspecified

5.2

95.3

258

262

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

6.3

95.3

217

182

N05AX15

ATC

cariprazine; oral

4.7

95.2

284

317

I49

ICD-10 Finland

Other cardiac arrhythmias

3.0

95.2

509

886

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

7.1

95.0

196

145

N05AE04

ATC

ziprasidone; systemic

4.3

95.0

312

380

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.7

95.0

629

1239

5AB14, ,

NOMESCO Finland

50.3

95.0

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

94.9

1397

3883

L02

ICPC

Back symptom/complaint

1.5

94.9

3726

13455

IGY02, ,

SPAT

2.6

94.8

684

1410

OAB72

NOMESCO Finland

Weight control and weight loss guidance

3.7

94.6

381

547

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

14.3

94.6

131

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.5

94.6

709

1490

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

94.4

9958

42359

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

94.4

2462

8098

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

94.2

1579

4581

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

93.5

2664

8954

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

93.5

2484

8208

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

93.5

505

885

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

93.4

2516

8342

K83

ICPC

Heart valve disease NOS

10.2

93.3

152

S06.0

ICD-10 Finland

Concussion

1.5

93.3

3456

12327

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

93.3

1231

3293

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

12.9

93.1

135

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

92.7

12927

56951

FL1AC

NOMESCO Finland

Left cardioangiography

8.2

92.4

172

110

Z72.2

ICD-10 Finland

Drug use

4.1

92.3

325

420

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.1

92.1

479

820

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.0

91.5

501

885

KMAK, ,

NOMESCO Finland

1.2

91.5

18777

86477

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

91.2

1527

4428

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

90.9

1422

4033

CK2S4, ,

SPAT

3.9

90.8

338

457

H3602, E103,

ICD-10 Finland

10.6

90.7

145

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

90.6

2017

6361

A10BD03

ATC

metformin and rosiglitazone; systemic

9.5

90.4

153

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

90.2

6090

24246

WVA20, ,

SPAT

2.2

90.2

942

2302

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

90.1

1984

6239

K99

ICPC

Cardiovascular disease other

3.8

90.0

340

465

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

3.8

89.8

345

478

XF600, ,

SPAT

2.4

89.7

719

1561

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.7

89.7

593

1167

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.3

89.7

837

1949

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

6.7

89.6

193

151

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

89.6

4312

16191

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

89.5

2329

7653

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

2.4

89.4

738

1625

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

89.3

3019

10552

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

89.2

2656

9019

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

40.6

89.1

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

8.6

89.0

160

P16

ICPC

Acute alcohol abuse

2.8

88.8

542

1021

D07AC13

ATC

mometasone; topical

1.3

88.6

8423

35270

A10AD05

ATC

insulin aspart; parenteral

6.0

88.5

208

181

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.8

88.3

1480

4293

L13

ICPC

Hip symptom/complaint

1.4

88.3

4348

16395

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

9.5

88.2

150

C02LM02, ,

ATC

47.1

88.2

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.6

88.1

359

520

F33

ICD-10 Finland

Recurrent depressive disorder

2.0

87.8

1068

2772

3055, ,

Kela drug reimbursment

4.5

87.7

277

326

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.3

87.4

823

1924

WX882

NOMESCO Finland

High dependency care

2.4

87.4

698

1513

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4.6

87.1

268

308

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.5

87.1

675

1442

K90

ICPC

Stroke/cerebrovascular accident

3.6

86.6

352

509

IHZ04, ,

SPAT

2.3

86.6

780

1788

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

11.9

86.6

130

J01CA08

ATC

pivmecillinam; oral

1.3

86.4

13308

59198

R12

ICD-10 Finland

Heartburn

1.6

86.2

2652

9072

R01AD01

ATC

beclometasone; nasal

1.4

86.2

4257

16056

I15.0

ICD-10 Finland

Renovascular hypertension

46.1

86.0

R74

ICPC

Upper respiratory infection acute

1.2

85.8

14650

65922

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.7

85.7

1993

6358

H3603, E113,

ICD-10 Finland

13.1

85.7

123

D01

ICPC

Abdominal pain/cramps general

1.4

85.5

4594

17588

B01AF03

ATC

edoxaban; oral

5.4

85.5

223

218

321

Kela drug reimbursment

Paricalcitol and cinacalcet

13.3

85.5

122

IEY01

NOMESCO Finland

Psychoeducation, individual

3.1

85.1

446

767

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

13.7

85.0

120

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

85.0

1127

3019

280

Kela drug reimbursment

Clopidogrel

71.6

85.0

123

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

84.7

2981

10507

L16

ICPC

Ankle symptom/complaint

1.4

84.7

3937

14679

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

84.7

1507

4453

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

0.6

84.5

1483

12971

SPAT1281

SPAT

Other administrative function

1.6

84.5

2125

6919

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

84.1

2019

6495

N06BA12

ATC

lisdexamfetamine; oral

2.4

83.9

689

1514

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

83.7

5474

21656

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.5

83.7

623

1305

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

83.6

1844

5798

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

83.5

1200

3307

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

83.5

2204

7265

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.6

83.3

586

1192

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.1

83.0

432

740

A98

ICPC

Health maint/preventive medicine

1.5

82.9

38799

196529

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

82.9

955

2427

Z01.7

ICD-10 Finland

Laboratory examination

1.4

82.8

5204

20452

R25.1

ICD-10 Finland

Tremor, unspecified

2.5

82.8

629

1331

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

11.2

82.5

128

R06AX22

ATC

ebastine; oral

1.4

82.5

5438

21538

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

82.1

3169

11386

XA800

NOMESCO Finland

Neuropsychological investigation

1.9

82.0

1194

3306

R33

ICD-10 Finland

Retention of urine

1.9

81.9

1281

3633

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.8

81.8

489

910

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

81.6

7465

31040

A08AA62

ATC

bupropion and naltrexone; systemic

4.2

81.5

278

350

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.2

81.5

781

1840

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

6.8

81.5

173

133

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

81.5

1427

4195

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

81.4

888

2208

S29

ICPC

Skin symptom/complaint other

1.3

81.4

5920

23805

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

8.3

81.2

150

C02DE02, ,

ATC

11.8

80.9

122

Q23.11

ICD-10 Finland

Bicuspid aortic valve

4.6

80.9

246

280

Z94.4

ICD-10 Finland

Liver transplant status

11.4

80.7

124

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.7

80.6

322

460

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

116.3

80.4

111

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

80.2

2335

7880

K06.18

ICD-10 Finland

Another gingival hyperplasia

8.0

80.2

152

100

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.9

80.0

460

837

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1239

1727

3.83

320.46

6.0

3.3

0.33

0.35

iu/ml

0.86

642

872

(3027456) Digoxin [Moles/volume] in Serum or Plasma

392

102

20.26

319.79

3.2

2.8

0.80

0.85

nmol/l

0.35

315

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1970

3748

2.83

319.59

5.0

2.8

51.73

48.01

6.74

1929

3695

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2322

4841

2.60

318.46

13.2

7.9

16.17

16.62

8.70

2241

4629

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

841

833

5.36

317.87

1.3

1.4

0.19

0.48

nmol/l

0.49

618

644

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1862

3470

2.89

312.94

2.2

1.8

1.42

1.30

g/l

5.31

1644

3005

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

885

948

4.96

309.57

23.5

21.0

1447.63

2286.61

nmol/l

0.39

865

911

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2318

4902

2.56

308.99

13.5

8.7

24.06

24.29

mmol/l

2.51

2278

4810

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1001

975

5.47

307.65

1.3

1.4

2.28

0.50

nmol/l

0.51

968

945

(3019069) Monocytes/Leukocytes in Blood

19869

75242

1.73

307.65

8.2

6.1

8.41

8.49

3.98

18911

71154

(3042936) Bacteria identified in Isolate by Culture

5928

17611

1.89

307.65

2.3

1.7

—

(3001604) Monocytes [#/volume] in Blood

21704

81247

1.84

307.65

8.0

6.0

0.57

0.53

e9/l

80.08

19199

71098

(40758558) Short blood count panel - Blood

12395

45169

1.62

307.65

7.2

5.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

4399

9376

2.62

307.65

10.1

6.7

12.69

14.47

kpa

58.13

4247

8997

(3027945) Reticulocytes/Erythrocytes in Blood

4202

10619

2.19

307.65

3.6

2.8

1.76

1.59

18.87

3848

9552

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3107

7173

2.37

307.65

13.1

6.9

24.62

24.76

mmol/l

1.35

3090

7118

(3026782) Osmolality of Urine

7782

24017

1.85

307.65

3.4

2.2

528.14

555.00

mosm/kgh2o

12.82

6942

20921

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

38813

181935

3.01

307.65

13.4

8.2

29.02

25.42

u/l

164.50

38209

177174

(3024354) Oxygen [Partial pressure] in Venous blood

3774

7690

2.72

307.65

5.8

3.0

4.82

4.67

kpa

3.18

3656

7485

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

36824

164788

2.59

307.65

5.7

3.6

2.76

2.95

mmol/l

307.65

35307

156571

(3020564) Creatinine [Moles/volume] in Serum or Plasma

39154

181414

3.63

307.65

20.4

10.2

74.47

69.86

umol/l

131.41

38914

178992

(3002582) Erythrocytes [#/volume] in Urine

12919

42934

1.83

307.65

4.2

2.5

66.09

68.73

e6/l

0.08

10052

31041

(40768446) Kidney Pathology biopsy report

481

107

23.74

307.65

2.0

1.1

—

(3006315) Basophils [#/volume] in Blood

21734

81355

1.84

307.65

8.1

6.0

0.04

e9/l

13.31

19202

71160

(3026250) Tacrolimus [Mass/volume] in Blood

575

123

24.75

307.65

48.6

32.1

7.30

7.14

ug/l

0.33

543

109

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4866

12030

2.26

307.65

1.9

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1026

979

5.59

307.65

1.3

1.4

0.28

0.36

nmol/l

0.25

(3003396) Base excess in Arterial blood by calculation

4368

9331

2.62

307.65

10.1

6.7

0.63

0.76

mmol/l

1.13

3561

7439

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4521

11834

2.12

307.65

4.6

4.8

233.73

234.29

u/l

0.08

4325

11315

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

35043

144262

2.81

307.65

6.3

3.4

38.87

36.14

mmol/mol

307.65

33655

136889

(3000991) Gas panel - Venous blood

3992

8229

2.70

307.65

13.0

7.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2662

4940

2.94

307.65

4.7

2.6

130.64

134.77

g/l

13.25

2584

4825

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1063

695

8.17

307.65

1.5

1.3

512.25

391.13

pmol/l

0.57

932

608

(36304419) Bacteria [Presence] in Urine

10847

36231

1.77

307.65

3.9

2.4

6.97

20.21

estimate

0.44

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3053

6294

2.66

307.65

5.7

3.3

5.10

5.11

kpa

0.16

2957

6011

(3015736) pH of Urine

18102

68051

1.70

307.65

3.8

2.6

6.21

6.23

1.76

10613

38549

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

36432

162899

2.47

307.65

5.1

3.4

1.38

1.52

mmol/l

307.65

34910

155110

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2299

4144

3.01

307.65

4.4

2.5

0.63

0.64

1.05

2288

4130

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3030

5726

2.90

307.65

6.8

3.4

24.05

24.32

mmol/l

4.52

2995

5670

(3026493) Urate [Moles/volume] in Serum or Plasma

10819

30501

2.16

307.65

2.8

2.0

335.66

304.89

umol/l

178.32

9914

27789

(3020891) Body temperature

1887

3355

3.03

307.65

5.1

3.4

36.94

36.92

°c

1.16

1867

3324

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

16735

61612

1.71

307.65

2.0

1.6

1.51

1.25

mmol/l

167.54

14625

54546

(3013512) EKG study

12393

33981

2.29

307.65

3.2

2.2

0.70

0.75

0.17

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

18717

71249

1.68

307.65

3.0

2.3

71.71

1299.97

nmol/l

0.50

17597

66928

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8035

24243

1.91

307.65

1.7

1.5

39931772.73

34202932.34

pmol/l

0.33

6992

20978

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2339

4641

2.73

307.65

7.2

5.3

24.26

24.39

mmol/l

0.75

2241

4385

(3014007) Fractional oxyhemoglobin in Arterial blood

2610

5114

2.78

307.65

13.0

9.0

93.94

94.85

8.61

2596

5101

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

28905

117298

1.96

307.65

4.8

3.5

10.34

8.38

mm/h

123.98

27556

110628

(3013115) Eosinophils [#/volume] in Blood

22337

84348

1.84

307.65

8.5

6.1

0.19

0.18

e9/l

4.21

20068

74826

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

20968

70767

2.12

307.65

6.6

5.7

10.45

10.90

umol/l

5.44

19959

66905

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2062

3476

3.21

307.65

8.8

4.0

1.41

1.04

mg/l

85.11

1965

3261

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

14676

39633

2.45

307.65

3.4

2.0

67.37

24.45

ng/l

2.09

8143

17746

(3009343) pH of Capillary blood

2977

6171

2.64

307.65

5.7

3.3

7.41

7.42

6.10

2530

5051

(3014111) Lactate [Moles/volume] in Serum or Plasma

3937

8481

2.58

307.65

10.5

6.3

1.31

1.29

mmol/l

0.63

3866

8316

(3022948) Iron [Moles/volume] in Serum or Plasma

7599

18985

2.34

307.65

3.2

1.8

14.00

15.16

umol/l

28.80

7190

17794

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

16223

55506

1.87

307.65

2.1

1.7

97.55

97.90

pmol/l

0.41

9188

29886

(3009261) Glucose [Presence] in Urine by Test strip

21986

86179

1.71

307.65

4.3

3.0

0.09

0.01

estimate

0.72

4543

16688

(3020779) Urea [Moles/volume] in Serum or Plasma

4193

6749

3.50

307.65

12.7

3.9

8.41

6.01

mmol/l

91.23

4080

6468

(3026008) Bacteria identified in Urine by Culture

11060

39065

1.65

307.65

2.9

2.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17651

53352

2.27

307.65

8.8

4.5

1.21

1.22

mmol/l

21.09

16616

49375

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5602

13258

2.40

307.65

2.3

2.2

368.71

388.83

nmol/l

9.81

5235

12417

(3023368) Bacteria identified in Blood by Culture

10181

29788

2.04

307.65

4.7

3.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6030

12717

2.73

307.65

9.9

3.9

1.07

1.04

mmol/l

10.10

5713

11725

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1026

948

5.77

307.65

2.8

2.2

173.43

21.14

ug/min

11.44

686

554

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10733

31230

2.08

307.65

2.3

1.6

0.97

1.04

mg/l

1.38

8070

22962

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3364

6312

2.94

307.65

6.0

2.3

90.53

60.17

ng/l

48.34

3053

5608

(3024561) Albumin [Mass/volume] in Serum or Plasma

17727

55523

2.17

307.65

6.0

4.3

36.85

37.15

g/l

9.42

16828

52153

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6552

17517

2.13

307.65

2.0

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

12404

32311

2.44

307.65

2.5

1.9

216.13

210.63

u/l

0.16

11867

30775

(3009508) Creatinine [Moles/volume] in Urine

15808

29316

3.95

307.65

4.4

2.7

8.22

8.60

mmol/l

11.48

14047

25981

(3001122) Ferritin [Mass/volume] in Serum or Plasma

21864

90792

1.55

307.65

3.9

2.9

100.28

83.62

ug/l

18.13

20904

86630

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4398

9378

2.62

307.65

10.1

6.7

5.06

kpa

0.08

4247

8993

(44816559) Phosphatidylethanol [Mass/volume] in Blood

3173

7181

2.42

307.65

2.0

1.6

0.29

0.25

mg/l

2.33

1539

3150

(3018418) pH of Serum or Plasma

12176

34536

2.20

307.65

5.2

3.0

7.39

7.40

3.69

8713

23268

(3002030) Lymphocytes/Leukocytes in Blood

20376

78625

1.70

307.65

8.1

5.9

28.96

30.29

60.09

19569

75151

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3753

7710

2.70

307.65

11.0

7.4

123.41

123.91

g/l

0.63

3674

7495

(3019977) pH of Arterial blood

4398

9423

2.61

307.65

10.3

6.7

7.41

7.42

2.25

2364

4927

(3042733) HLA Ab [Presence] in Serum

412

25.56

307.65

4.8

2.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

23874

78638

2.40

307.65

6.2

3.6

6.62

6.13

mmol/l

168.89

22638

71469

(3037522) Nuclear Ab [Titer] in Serum

7397

23046

1.82

307.65

1.5

1.4

528.86

510.99

titre

0.29

1440

4361

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

7773

24915

1.78

307.65

2.2

1.6

1.47

1.33

46.10

7024

22722

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2680

4167

3.52

307.65

3.3

1.9

149.49

72.41

ng/l

14.91

2384

3609

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6570

15249

2.49

307.65

3.1

2.0

29.55

28.96

12.12

6388

14794

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

29691

113691

2.31

307.65

8.9

6.7

76.59

74.88

u/l

9.03

28503

108006

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11186

34682

1.94

307.65

2.5

2.1

2.67

2.52

mg/l

9.84

9881

29848

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16028

51195

2.04

307.65

3.8

2.9

31.87

30.73

u/l

0.80

15277

48853

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4556

8970

2.86

307.65

6.4

3.1

5.84

kpa

0.02

4424

8732

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

16882

65399

1.59

307.65

4.0

2.7

0.06

0.23

estimate

1.27

4056

13953

(3031040) Bacteria [#/volume] in Urine by Automated count

25038

104566

1.64

307.65

5.0

3.6

1158.62

1481.13

e6/l

0.53

386

1236

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

36195

155953

2.76

307.65

14.9

8.2

91.63

93.46

ml/min/173m2

47.39

33653

137327

(3032080) INR in Blood by Coagulation assay

16827

47971

2.41

307.65

11.5

4.6

1.16

1.07

inr

108.24

14130

38939

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1657

2665

3.34

307.65

4.2

2.3

24.13

24.66

mmol/l

6.19

1634

2608

(3011985) Renin [Units/volume] in Plasma

1122

833

7.20

307.65

1.7

2.3

72.83

51.66

mu/l

0.94

1030

774

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7242

17625

2.39

307.65

5.2

3.4

0.82

0.83

mmol/l

14.69

6898

16628

(3002032) Base excess in Venous blood by calculation

4447

8734

2.86

307.65

6.4

3.1

1.45

1.82

mmol/l

8.23

3884

7551

(3012516) Albumin [Mass/volume] in Urine

13184

19081

4.84

307.65

4.1

2.9

66.93

44.73

mg/l

11.06

9002

10954

(3012544) pH of Venous blood

4593

8966

2.89

307.65

6.4

3.1

7.37

7.38

1.72

2685

5045

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13616

43285

1.96

307.65

3.2

2.3

61.63

76.55

u/l

0.48

12780

40230

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

36004

154449

2.74

307.65

6.4

4.5

1.77

1.78

mu/l

0.62

34507

145837

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2864

4625

3.40

307.65

2.4

1.6

7.39

5.10

ug/l

5.41

2565

3911

(3013650) Neutrophils [#/volume] in Blood by Automated count

23635

91844

1.81

307.65

12.0

8.6

4.18

3.81

e9/l

106.05

20951

79929

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2541

5006

2.76

307.65

13.2

9.1

0.65

0.67

1.62

2523

4979

(3015377) Calcium [Moles/volume] in Serum or Plasma

13698

44802

1.89

307.65

3.3

2.35

mmol/l

0.22

12752

41466

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4699

11500

2.28

307.65

1.9

1.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2323

4168

3.03

307.65

4.5

2.6

1.37

1.34

0.40

2310

4147

(3020682) Albumin/Creatinine [Ratio] in Urine

13378

19290

4.89

307.65

4.8

3.5

12.88

6.69

mg/mmol

5.25

9020

11150

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

29067

125495

1.71

307.65

4.1

2.7

45.18

33.23

u/l

121.24

27978

120410

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2611

5104

2.79

307.65

12.9

8.9

1.39

1.30

3.38

2595

5073

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

32144

131203

2.28

307.65

5.3

3.9

14.60

14.31

pmol/l

88.53

30527

122030

(3023520) Reticulocytes [#/volume] in Blood

3183

7343

2.37

307.65

3.2

2.8

71.79

67.61

e9/l

5.86

2275

5169

(3018010) Neutrophils/Leukocytes in Blood

20092

77317

1.70

307.65

7.9

5.8

56.80

55.41

57.18

19397

74314

(3023103) Potassium [Moles/volume] in Serum or Plasma

38433

161052

4.74

307.65

18.8

8.5

3.94

3.92

mmol/l

42.20

37962

156013

(3022096) Basophils/Leukocytes in Blood

19790

75033

1.73

307.65

8.2

6.1

0.67

0.69

7.29

18767

70749

(3033658) Prothrombin time (PT) actual/Normal

10658

34956

1.80

307.65

5.1

3.3

94.20

94.74

1.38

10383

34143

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

19674

60722

2.33

307.65

9.2

4.9

1.21

1.22

mmol/l

24.50

17269

52376

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9811

17091

3.62

307.65

3.6

1.8

1083.91

395.42

ng/l

36.98

8094

13137

(3019198) Lymphocytes [#/volume] in Blood

22156

83969

1.82

307.65

8.1

5.9

2.02

1.96

e9/l

4.96

20066

75160

(3018095) Leukocytes [#/volume] in Urine

14991

54302

1.70

307.65

5.0

3.0

62.55

73.39

e6/l

1.13

10796

34428

(3021589) Normoblasts [#/volume] in Blood

18565

72852

1.60

307.65

12.8

8.5

0.00

e9/l

0.95

15277

59203

(3006504) Eosinophils/Leukocytes in Blood

19800

75106

1.73

307.65

8.1

6.1

2.74

2.85

10.24

18818

70944

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6512

15121

2.48

307.65

3.4

1.8

23.51

25.10

13.77

6137

14046

(3037467) Urinalysis macro (dipstick) panel - Urine

26773

109568

1.79

307.65

5.1

3.6

2.64

5.72

0.46

156

(3035350) Ketones [Presence] in Urine by Test strip

21901

85514

1.72

307.65

4.2

2.9

5.68

3.28

estimate

1.00

4800

16909

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7657

18496

2.43

307.65

3.9

2.2

457.50

225.76

ng/l

5.31

4911

9626

(3016502) Oxygen saturation in Arterial blood

3959

8027

2.74

307.65

10.7

7.2

95.93

96.62

7.90

3826

7712

(3000850) Epithelial cells [#/volume] in Urine

9212

27774

1.94

307.65

3.4

2.1

6.52

6.88

e6/l

1.17

8500

24839

(3029937) Albumin [Presence] in Urine by Test strip

12106

43752

1.63

307.65

4.4

3.0

0.01

estimate

0.20

4505

16135

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

37166

171756

2.35

307.65

17.2

9.6

20.38

22.15

mg/l

20.70

31640

131181

(3019309) Folate [Moles/volume] in Red Blood Cells

5688

15920

2.01

307.65

1.7

1.6

1171.85

1137.15

nmol/l

1.91

4539

12136

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2644

5509

2.61

307.65

5.8

3.3

1.32

1.35

mmol/l

0.15

1901

3923

(3019550) Sodium [Moles/volume] in Serum or Plasma

38309

160738

4.55

307.65

18.6

8.5

139.59

139.73

mmol/l

27.45

37860

156262

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

35424

150771

2.63

307.65

5.0

3.2

5.92

5.48

mmol/l

307.65

33631

141400

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

36585

163759

2.50

307.65

5.2

3.4

4.62

4.87

mmol/l

307.65

35187

156358

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

14281

47145

1.89

307.65

4.3

2.5

1.69

1.91

e6/l

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7089

17108

2.41

307.65

3.3

1.7

2.42

2.45

g/l

4.46

6634

15764

(3044889) 12 lead EKG panel

28253

92342

2.91

307.65

3.8

2.3

8957.61

0.72

0.68

(3030467) Casts [#/volume] in Urine by Automated count

11210

37023

1.80

307.65

4.0

2.4

0.33

0.29

e6/l

1.17

8373

25357

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

34883

151655

2.32

307.65

4.4

3.0

1.39

1.15

mmol/l

307.65

33245

143816

(3021601) Nitrite [Presence] in Urine by Test strip

21677

84611

1.71

307.65

4.2

2.9

0.00

estimate

0.31

4755

16892

(3021960) Folate [Moles/volume] in Serum or Plasma

10450

32606

1.90

307.65

1.7

1.5

19.10

20.24

nmol/l

12.91

9321

28591

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6934

22539

1.73

299.72

3.4

2.3

1.00

1.12

e6/l

0.32

3678

10679

(3007853) Bacteria identified in Skin by Aerobe culture

5419

16369

1.84

298.56

1.9

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2850

6763

2.29

297.90

2.4

2.6

66.73

67.31

g/l

3.16

2681

6279

(3027273) Bicarbonate [Moles/volume] in Venous blood

1776

3316

2.88

297.26

4.9

2.4

24.93

25.44

mmol/l

6.93

1703

3193

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3803

10190

2.05

295.54

4.0

3.2

4.66

4.63

pmol/l

0.71

3476

9240

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

846

909

4.94

294.95

18.1

15.1

2983.77

764.55

nmol/l

0.76

827

878

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7015

22974

1.72

294.75

2.6

2.8

2.42

mmol/l

3.93

6269

20667

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5269

15836

1.85

294.58

3.5

2.5

6.59

7.70

umol/l

3.82

4495

13635

(3019150) Specific gravity of Urine by Refractometry

10429

37863

1.59

294.18

4.2

2.8

1.16

1.19

kg/l

0.05

6829

23745

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

3443

8928

2.11

290.98

3.1

2.1

73.00

84.27

ml/min/173m2

38.01

1444

3245

(3005719) IgG [Mass/volume] in Serum or Plasma

4134

11523

1.97

288.21

2.9

2.8

10.35

10.59

g/l

3.05

3854

10661

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4003

11032

1.99

287.98

2.7

2.5

0.22

g/l

0.94

3771

10414

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

283

57.24

284.49

7.9

4.7

2401.96

717.00

iu/ml

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

18151

75048

1.47

275.24

3.0

2.5

—

estimate

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

12312

47077

1.52

272.07

1.4

1.61

1.76

u/ml

0.57

3681

13417

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4211

12050

1.92

271.43

6.1

3.7

—

(3024928) Oxygen saturation in Venous blood

1274

2059

3.30

268.13

4.8

3.0

65.19

62.20

4.02

1237

1991

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3213

8420

2.08

263.19

4.6

3.0

1.23

mmol/l

0.55

2811

7154

(3011397) Hemoglobin [Presence] in Urine by Test strip

9944

36495

1.56

262.31

4.2

2.9

0.33

0.21

0.51

217

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2015

4326

2.51

259.67

2.2

1.7

1.20

1.15

g/l

10.29

1943

4154

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1967

4175

2.53

259.31

2.3

1.7

0.23

0.22

g/l

9.68

1894

3994

(40768797) Stomach Pathology biopsy report

5608

17947

1.73

251.61

1.2

—

(3021901) Oxygen saturation in Capillary blood

1040

1539

3.60

248.02

4.0

2.1

91.92

91.95

0.05

1016

1495

(3007164) IgA [Mass/volume] in Serum or Plasma

10696

40309

1.52

247.83

1.6

1.4

2.23

2.14

g/l

6.44

7157

26132

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

8716

31426

1.57

245.61

1.4

1.3

26.47

29.44

iu/ml

0.39

2453

9067

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1581

3105

2.73

241.26

2.8

1.9

399.60

350.08

ug/l

0.32

1471

2797

(3007461) Platelets [#/volume] in Blood

39509

195956

2.33

238.83

27.2

14.4

264.51

257.51

e9/l

85.64

39106

191783

(3028026) IgM [Mass/volume] in Serum or Plasma

3216

8756

2.00

236.98

1.8

1.9

1.24

1.35

g/l

2.48

3019

8145

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6365

21457

1.65

234.41

3.6

2.3

3.67

3.30

e6/l

1.22

3089

9556

(3035941) MCH [Entitic mass]

39510

196126

2.31

233.12

27.1

14.3

30.09

30.11

2.17

39320

194306

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

39511

196142

2.31

232.80

27.9

14.5

41.24

41.83

1.67

39313

194179

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2036

4627

2.37

232.54

1.7

1.5

16.28

10.14

iu/ml

0.89

150

(3024731) MCV [Entitic mean volume] in Red Blood Cells

39506

196119

2.31

232.37

27.1

14.3

90.07

90.04

0.73

39317

194285

(3026361) Erythrocytes [#/volume] in Blood

39511

196161

2.31

232.14

27.2

14.3

4.58

4.57

e12/l

6.46

39015

191551

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3303

9145

1.96

232.13

3.0

1.9

0.40

0.28

e6/l

1.64

3121

8674

(3010813) Leukocytes [#/volume] in Blood

39516

196217

2.31

231.42

27.3

14.4

6.94

6.48

e9/l

258.23

39020

191565

(3041096) Erythrocytes [Presence] in Urine by Automated

12696

50126

1.47

231.23

3.4

2.4

0.11

0.15

estimate

0.23

3950

13843

(3000963) Hemoglobin [Mass/volume] in Blood

39515

196247

2.30

230.13

27.4

14.4

137.01

g/l

0.04

39328

194436

(1616796) Gas panel - Central venous blood

1154

1933

3.18

229.78

4.7

2.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

411

247

8.77

229.46

32.7

20.1

120.42

139.65

ug/l

1.67

339

220

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1147

1919

3.18

228.80

6.0

2.2

856.33

14482.93

u/ml

1.23

111

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7971

28629

1.56

225.59

1.3

7.21

9.77

u/ml

3.73

3321

11752

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

32476

153047

1.51

224.98

21.5

11.6

13.43

13.25

125.43

32149

150769

(3017732) Neutrophils [#/volume] in Blood

5720

19018

1.66

220.77

3.5

2.7

4.57

4.12

e9/l

2.93

5155

16847

(3018405) Lactate [Moles/volume] in Arterial blood

1235

2213

2.97

220.73

4.0

3.4

1.38

1.42

mmol/l

0.43

1213

2166

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

9671

36403

1.51

220.52

2.6

2.0

—

(3017181) Myelocytes/Leukocytes in Blood

3984

11963

1.82

218.97

5.3

4.5

0.81

0.94

1.78

1217

3045

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3713

10913

1.85

218.22

3.3

2.5

—

(3002179) Metamyelocytes/Leukocytes in Blood

3831

11381

1.84

217.75

5.0

4.3

0.59

0.70

1.96

1172

2906

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1131

1946

3.09

215.85

4.1

1.8

0.96

0.70

nmol/l

20.93

965

1699

(3025159) Blasts/Leukocytes in Blood

3908

11727

1.82

215.02

5.7

4.7

0.15

0.28

0.63

1017

2504

(3028626) Oxygen [Partial pressure] in Capillary blood

1462

2932

2.66

214.33

7.4

3.9

9.07

9.12

kpa

0.40

1435

2845

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2949

8156

1.96

206.92

1.8

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

420

304

7.28

206.54

1.4

165.85

146.14

mmol/24h

2.78

420

304

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1359

2674

2.71

206.29

9.1

3.3

588.90

499.95

iu/ml

0.25

213

221

(3014051) Protein [Presence] in Urine by Test strip

12400

49556

1.44

206.26

3.1

2.3

0.08

0.03

0.86

142

622

(3010421) pH of Blood

1453

2987

2.60

203.11

4.6

2.3

7.41

2.51

1437

2935

(3021440) Promyelocytes/Leukocytes in Blood

3814

11558

1.80

202.64

5.5

4.5

0.08

0.13

3.01

1047

2653

(3020876) Protein [Mass/time] in 24 hour Urine

558

610

4.83

190.94

2.9

2.5

1.77

0.90

g/24h

6.16

369

311

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

198

38.48

188.00

6.3

5.4

2.30

1.96

mg/l

0.37

175

(3036489) Thrombin time

2203

5660

2.09

187.80

3.2

2.0

20.68

20.28

2.68

1928

4841

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1403

2948

2.54

187.77

2.1

1.8

2.45

2.27

ug/l

0.10

1267

2607

(3043409) Potassium [Moles/volume] in Arterial blood

1034

1836

2.99

187.39

4.2

3.6

3.86

3.80

mmol/l

3.59

1024

1816

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4253

13688

1.69

182.54

3.0

2.3

47.91

47.75

u/l

0.00

3604

11800

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1771

4216

2.25

181.51

1.3

—

(3024932) HLA-DR beta [Type]

315

182

9.10

180.25

1.1

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1609

3705

2.32

177.71

5.8

3.8

1.76

1.70

0.97

1514

3473

(3024471) HLA-A [Type]

317

193

8.64

175.56

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1798

4393

2.19

173.23

2.4

2.0

3.84

14.37

iu/l

0.48

818

1858

(3023183) Ammonium ion [Moles/volume] in Plasma

1018

1898

2.85

169.82

3.4

2.4

34.18

33.17

umol/l

0.54

948

1738

(3007930) Methemoglobin/Hemoglobin.total in Blood

1474

3344

2.35

168.07

6.1

4.1

0.88

0.92

1.81

1385

3126

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1633

3887

2.24

167.19

6.5

3.7

24.48

24.56

mmol/l

0.55

1555

3672

(40767503) Oxygen content in Capillary blood by calculation

984

1830

2.85

164.84

3.0

1.8

17.23

17.42

1.02

964

1785

(3037121) Protein [Mass/volume] in Urine

1629

3931

2.21

161.45

5.1

2.9

481.67

324.17

mg/l

1.51

929

1809

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1862

4746

2.10

161.45

4.1

2.4

3.56

3.51

g/l

0.68

1783

4525

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1960

5133

2.04

158.38

4.2

2.3

96.25

95.79

0.37

1901

4923

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

988

1898

2.76

156.29

3.1

3.9

38.91

28.16

mg/l

2.07

834

1647

(3034860) Kappa light chains.free [Mass/volume] in Serum

989

1903

2.76

155.99

3.1

3.9

58.47

38.50

mg/l

1.73

833

1648

(3023420) DNA double strand Ab [Units/volume] in Serum

2321

6503

1.92

155.45

2.3

1.8

9.53

6.69

iu/ml

0.67

572

1462

(3027315) Oxygen [Partial pressure] in Blood

1000

1945

2.73

154.69

4.7

2.5

9.13

9.15

kpa

0.14

984

1893

(3048689) Calprotectin [Mass/mass] in Stool

7184

27072

1.47

154.42

2.6

2.9

109.64

114.83

ug/g

0.68

5786

21623

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2172

5965

1.95

154.04

1.6

1.5

—

(3013290) Carbon dioxide [Partial pressure] in Blood

997

1941

2.72

153.95

4.7

2.5

4.99

5.00

kpa

0.07

981

1889

(3012501) Base excess in Blood by calculation

996

1941

2.72

153.52

4.7

2.5

2.10

2.20

mmol/l

0.49

623

1198

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

706

1114

3.35

153.52

1.2

28.19

41.04

nmol/l

0.67

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2103

5722

1.97

153.08

2.1

1.9

38.84

41.48

u/l

6.90

1919

5487

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1544

3727

2.21

152.80

1.9

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1834

4757

2.06

151.86

3.6

2.4

178.88

166.59

7.14

1761

4504

(3017143) Hepatitis C virus Ab [Presence] in Serum

7501

28633

1.45

150.37

1.9

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1534

3728

2.19

149.35

1.8

1.2

19.36

22.28

u/ml

0.32

(3003181) Sodium [Moles/volume] in Urine

695

1106

3.32

149.25

1.5

1.8

64.40

72.54

mmol/l

3.22

573

855

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

543

722

3.97

148.70

1.4

1.5

1.49

1.26

nmol/l

3.41

486

669

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1291

2917

2.35

148.30

1.8

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1612

4012

2.14

148.13

1.6

1.2

245.38

224.30

u/ml

2.20

1045

2489

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2181

6083

1.92

147.83

1.3

1.2

0.84

1.05

u/ml

0.34

173

369

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

890

1671

2.82

146.58

2.9

3.7

2.54

5.98

ratio

1.26

505

933

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1455

3488

2.22

146.26

1.9

1.2

138.17

141.30

au/ml

0.37

402

988

(3034770) Mitochondria Ab [Titer] in Serum

1569

3882

2.16

146.25

1.3

1132.11

896.26

titre

0.43

107

(3024666) Lithium [Moles/volume] in Serum or Plasma

688

1106

3.29

145.54

13.5

12.6

0.59

0.61

mmol/l

0.78

628

1029

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

549

759

3.82

143.11

1.4

20.85

2.56

u/ml

—

(3007566) Smooth muscle Ab [Titer] in Serum

1602

4048

2.11

141.67

1.3

89.40

126.40

titre

1.34

166

392

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1678

4319

2.07

141.57

1.6

1.2

36.07

40.38

u/ml

0.29

(3011288) Drugs identified in Urine by Screen method Nominal

3307

10624

1.68

140.87

4.6

2.5

—

(3047181) Lactate [Moles/volume] in Blood

1237

2837

2.32

137.44

6.4

4.1

1.28

1.22

mmol/l

1.11

1083

2487

(3009466) Valproate [Moles/volume] in Serum or Plasma

970

1977

2.60

137.43

6.3

5.5

368.22

379.88

umol/l

1.35

859

1735

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

723

1248

3.06

137.03

1.3

28.89

37.02

u/l

0.62

634

1105

(3045414) Leukocytes [Presence] in Urine

3782

12674

1.62

136.69

2.2

1.8

0.02

0.04

estimate

0.93

879

3058

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1067

2301

2.46

135.15

1.1

77.76

4608.15

iu/ml

0.64

244

592

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1217

2796

2.31

134.68

1.8

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1153

2635

2.32

129.05

1.4

1.2

—

(3004775) Volume in Urine collected for unspecified duration

324

304

5.60

128.81

2.7

1.9

651.00

609.73

0.72

243

230

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

3010

9671

1.67

127.61

1.5

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

1112

2516

2.34

127.21

1.1

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1374

3407

2.14

127.17

2.3

1.9

11.49

10.12

mg/l

4.46

1301

3230

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

812

1572

2.73

126.59

1.4

15.44

14.52

u/ml

0.05

(3019225) pH of Specimen

3261

10744

1.64

125.52

4.5

3.0

7.36

7.35

0.85

2498

7345

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

614

1023

3.17

123.03

8.0

5.6

11.00

10.09

mg/l

4.02

573

952

(3000034) Microalbumin [Mass/volume] in Urine

397

478

4.37

122.37

3.2

2.7

113.39

53.77

mg/l

1.59

308

306

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1303

3245

2.13

119.24

1.6

1.4

10.26

9.15

iu/ml

0.12

(40760888) Immunoglobulin light chains.free panel - Serum

675

1220

2.92

118.63

3.1

4.1

—

1026.72

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

622

1071

3.06

118.36

1.1

1.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1249

3075

2.16

117.56

2.0

2.3

3.70

3.66

g/l

0.33

1178

2846

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1249

3076

2.16

117.46

2.0

2.3

4.25

4.23

g/l

0.51

1177

2846

(3005322) IgE [Units/volume] in Serum or Plasma

3768

13056

1.56

117.41

1.4

1.3

229.74

252.58

u/ml

0.44

3515

12185

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1249

3080

2.15

117.09

2.0

2.3

7.31

6.94

g/l

9.94

1178

2847

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1062

2445

2.30

116.87

2.5

1.8

132.76

134.35

g/l

1.26

876

1913

(3000494) Fungus identified in Specimen by Culture

4982

18365

1.47

116.21

1.6

1.4

—

(3016750) Collection duration of Urine

277

245

5.94

116.13

2.7

1.7

508.31

510.30

min

0.10

218

198

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

411

539

4.01

114.55

1.7

1.6

3.94

2.13

nmol/l

1.09

325

424

(3048929) Epstein Barr virus Ab [Presence] in Serum

2700

8671

1.67

114.18

1.5

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1313

3370

2.07

111.26

1.4

295.23

304.13

ug/g

0.64

682

1791

(3052851) Hemolysis interference index of Serum or Plasma

1239

3115

2.11

110.67

3.1

2.4

2.22

2.60

index

0.56

697

1571

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1191

2961

2.13

109.38

2.0

2.3

2.89

2.77

g/l

3.11

1120

2729

(3020911) Cortisol [Moles/time] in 24 hour Urine

328

368

4.68

109.32

1.4

179.01

284.67

nmol/24h

0.36

328

368

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1116

2712

2.18

108.34

1.6

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1193

2980

2.12

108.28

1.8

1.5

—

(3042517) Benzodiazepines panel - Urine

262

238

5.78

107.32

2.9

2.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

429

614

3.68

106.94

3.2

2.5

176.56

156.08

umol/l

0.45

225

311

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4304

15650

1.49

106.74

1.3

1.2

134.04

151.38

u/ml

1.72

1641

6017

(3028271) Lactate [Moles/volume] in Capillary blood

721

1438

2.65

106.39

2.1

1.6

1.66

1.74

mmol/l

1.03

708

1398

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

924

2086

2.34

106.13

1.6

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

828

1783

2.45

105.10

1.9

1.7

—

(3012565) Volume of 24 hour Urine

313

350

4.70

104.71

2.1

2.3

2006.82

2122.28

0.76

296

327

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

634

1202

2.78

102.62

1.6

1.2

76.01

77.94

0.17

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

848

1869

2.40

102.55

1.3

1.2

378.79

313.99

titre

0.26

138

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

856

1904

2.38

101.52

1.3

1.2

223.75

140.61

titre

0.21

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1082

2684

2.14

99.87

2.1

2.4

0.57

0.75

g/l

0.87

972

2379

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1069

2648

2.14

99.01

2.0

2.2

10.24

10.45

g/l

0.66

992

2392

(3003129) Base excess in Capillary blood by calculation

490

822

3.14

97.21

2.1

1.8

0.26

0.72

mmol/l

1.87

457

757

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

928

2184

2.25

97.10

2.0

2.1

0.00

g/l

1.15

831

1958

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

793

1739

2.41

96.92

1.7

1.5

—

(40761536) Microorganisms panel - Urine sediment

3635

13041

1.50

95.55

4.3

2.9

—

(3039000) Anion gap in Blood by calculation

789

1740

2.40

95.29

8.1

5.4

11.45

11.25

mmol/l

0.77

706

1547

(3018572) Chloride [Moles/volume] in Blood

789

1741

2.39

95.18

8.1

5.4

105.25

105.58

mmol/l

0.95

706

1548

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

643

1283

2.64

94.81

1.8

1.4

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

32439

159018

1.31

94.62

22.2

11.6

333.36

333.51

g/l

2.06

32310

157962

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

966

2344

2.18

94.06

2.0

2.1

0.01

0.03

g/l

0.55

887

2150

(4198724) Urine methamphetamine measurement

630

1259

2.64

92.63

3.7

2.2

—

(36660697) Celiac disease serology panel - Serum

4353

16303

1.44

91.91

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1646

4888

1.79

91.08

1.3

30.52

40.11

u/ml

0.65

264

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

931

2258

2.18

90.75

1.5

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

523

955

2.88

90.39

3.5

1.9

96.77

100.22

1.28

497

871

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1550

4529

1.82

90.36

1.3

12.49

9.16

u/ml

0.66

200

613

(3022145) Colonoscopy Study observation

4490

16983

1.43

89.73

1.4

1.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

112

18.92

89.68

6.2

3.1

69927.50

1384271.43

u/ml

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

874

2075

2.23

89.60

2.1

2.2

0.00

g/l

-0.00

829

1956

(3020191) Ethanol [Moles/volume] in Serum or Plasma

619

1253

2.60

88.84

1.7

1.4

1.30

1.45

promille

1.41

497

992

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1457

4212

1.84

87.83

1.4

460.53

508.35

mg/l

1.33

1393

4034

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1541

4535

1.80

87.77

1.3

11.97

6.84

u/ml

0.71

134

415

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

109

18.41

86.50

6.0

3.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

255

285

4.70

85.44

2.7

2.0

24.52

52.90

umol/l

1.56

(4146454) Self-monitoring of blood glucose

359

533

3.54

85.24

2.7

2.9

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1313

3706

1.88

85.16

1.3

1.4

3.70

3.49

mmol/l

10.89

1244

3495

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

692

1522

2.40

84.06

1.5

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

698

1542

2.39

84.00

1.8

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

698

1543

2.39

83.89

1.8

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

698

1545

2.38

83.66

1.8

1.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

24.18

83.46

8.0

2.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

698

1547

2.38

83.43

1.8

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

780

1839

2.24

81.27

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

636

1369

2.45

80.83

1.9

1.4

—

(3045424) Erythrocytes [Presence] in Urine

2038

6656

1.63

80.00

2.3

1.7

0.02

0.13

estimate

0.59

701

2541

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7474

31163

1.31

79.87

4.3

2.13

2.88

ug/l

2.24

6821

28703

(3040151) Glucose [Moles/volume] in Capillary blood

554

1120

2.61

79.73

5.4

2.5

7.49

6.52

mmol/l

2.85

487

910

(3016650) Hepatitis A virus Ab [Presence] in Serum

1100

2996

1.94

79.17

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1301

3749

1.84

79.14

1.5

1641.78

2016.01

e6/l

0.12

1002

2916

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1270

3637

1.85

78.76

1.3

14.97

15.30

u/ml

0.01

(3037756) Immunofixation for Serum or Plasma

605

1288

2.48

78.65

1.5

2.1

—

(3008295) Osmolality of Serum or Plasma

531

1060

2.64

78.29

1.7

1.9

282.76

284.97

mosm/kgh2o

1.15

411

837

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1281

3699

1.83

77.41

1.5

23.61

30.62

e6/l

0.41

931

2719

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3298

23882

0.70

77.13

1.5

1.6

938.37

1027.07

mu/l

5.08

2747

20470

(3045716) Anion gap in Serum or Plasma by calculation

445

812

2.88

77.07

3.3

2.5

10.61

10.51

mmol/l

0.20

437

798

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1260

3627

1.84

76.89

1.3

6.77

3.19

u/ml

0.52

237

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1049

2855

1.94

75.64

1.3

1.2

4.20

3.87

u/ml

0.29

524

1365

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

106

92.51

75.28

7.8

12.7

6.23

4.73

mmol/l

—

106

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1313

3859

1.80

74.99

1.3

1.2

41.09

45.64

u/ml

0.34

121

290

(3022806) Fractional oxyhemoglobin in Capillary blood

548

1144

2.52

74.12

2.0

1.5

91.29

91.16

0.22

540

1122

(3021387) Prolactin [Units/volume] in Serum or Plasma

3156

11575

1.46

73.42

1.7

1.6

336.36

297.90

mu/l

5.04

2879

10394

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3357

12491

1.44

72.37

2.4

19.41

19.32

au/ml

0.03

401

1826

(3000492) Spirometry study

4603

18094

1.37

72.37

1.5

1.4

—

20.98

—

(3025941) Bacteria identified in Stool by Culture

2813

10112

1.49

72.32

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3159

11632

1.45

71.94

1.3

48.55

46.16

au/ml

0.20

154

748

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

126

8.92

71.58

6.2

3.0

41.84

27.56

ug/min

0.88

(3016244) Insulin [Units/volume] in Serum or Plasma

644

1477

2.30

71.47

3.3

3.1

26.61

23.63

mu/l

1.15

620

1382

(3023511) Choriogonadotropin [Units/volume] in Urine

2222

7620

1.55

71.02

1.5

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

781

1952

2.11

70.72

3.2

2.2

1.47

1.42

mmol/l

0.72

756

1908

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2672

9569

1.49

69.89

1.2

1.1

23.29

9.16

u/ml

0.51

115

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

215

249

4.53

69.42

3.1

2.3

0.60

0.63

mmol/l

4.21

215

249

(21494890) Protein electrophoresis panel - 24 hour Urine

328

530

3.25

69.05

2.0

2.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

929

2508

1.96

68.54

2.5

2.6

31.36

29.63

iu/ml

0.09

153

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1060

2994

1.87

68.53

1.3

1.2

3.44

3.36

u/ml

0.05

424

1176

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3950

15269

1.39

68.50

4.4

3.2

30.53

32.32

19.83

2969

10602

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

204

228

4.69

68.46

2.1

1.6

137.96

8.64

ug/min

2.16

(3016038) Potassium [Moles/volume] in Urine

302

465

3.41

68.24

1.3

2.0

33.36

36.05

mmol/l

0.91

278

430

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

133

7.57

67.82

1.3

1.2

415.50

405.08

pmol/l

0.03

(3024980) IgG subclass 4 [Mass/volume] in Serum

969

2665

1.92

67.80

1.6

0.71

0.76

g/l

0.79

747

2131

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

781

1985

2.08

67.78

2.9

1.9

—

(3036603) Volume of Urine

393

727

2.84

66.55

1.6

1.7

2159.89

2060.10

0.87

387

722

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

339

577

3.09

65.89

1.2

1.3

—

(3004451) EKG impression Narrative

200

229

4.58

65.42

1.3

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

150

128

6.14

65.04

3.0

2.4

32.19

17.47

mg/l

1.11

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

135

102

6.93

64.54

7.8

4.7

5.88

6.08

kpa

1.06

127

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1047

3009

1.84

64.17

2.6

2.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

296

475

3.27

63.01

1.8

2.1

1.45

1.21

nmol/l

2.14

228

393

(3044290) Cell count panel - Cerebral spinal fluid

1190

3584

1.76

62.62

1.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

162

158

5.37

62.36

7.4

3.6

24.51

24.83

mmol/l

0.31

154

145

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

966

2732

1.87

62.21

1.1

116.26

116.28

0.01

899

2479

(3038071) Oxygen [Partial pressure] in Mixed venous blood

126

7.17

61.82

7.7

4.8

5.74

5.41

kpa

0.48

126

(4268621) Lupus anticoagulant assay

786

2086

1.99

60.83

2.5

2.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1297

4046

1.70

60.33

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4017

15875

1.36

60.31

2.6

2.5

6920.88

6507.43

u/l

0.27

1368

6743

(4195642) Thrombophilia screening test

955

2721

1.85

60.12

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

212

275

4.04

60.12

8.5

3.0

301.91

27.20

mg/mmol

0.68

200

248

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

541

1246

2.28

59.54

1.7

1.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

994

2902

1.81

57.96

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1013

2981

1.79

57.57

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

501

1132

2.33

57.55

1.1

288.77

286.09

mg/l

0.25

462

1050

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

128

107

6.26

56.52

4.5

2.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

354

679

2.74

56.32

2.4

2.5

153.08

146.28

nmol/l

0.49

307

598

(3009214) Lutropin [Units/volume] in Serum or Plasma

2356

8587

1.46

56.08

1.5

8.41

8.91

u/l

1.14

1917

6883

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

481

1084

2.33

55.59

1.7

1.8

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

636

1620

2.07

54.95

1.4

1.3

2.94

3.00

g/l

0.36

457

1192

(4062490) Immunoglobulin typing, IgG

631

1603

2.07

54.89

1.4

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

635

1619

2.06

54.73

1.4

1.3

0.34

0.41

g/l

3.69

453

1188

(3027135) IgG subclass 1 [Mass/volume] in Serum

635

1619

2.06

54.73

1.4

1.3

6.48

6.75

g/l

1.05

455

1192

(3004809) Band form neutrophils/Leukocytes in Blood

685

1806

2.00

54.01

3.6

3.0

1.27

1.70

2.06

636

1619

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

738

2001

1.94

53.83

1.1

1.47

1.43

g/l

1.55

689

1835

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

638

1647

2.04

53.24

2.5

2.8

22.62

21.95

nmol/l

0.67

613

1589

(3029634) Reagin Ab [Titer] in Serum by VDRL

1063

3249

1.73

53.16

2.1

2.3

11.43

7.51

titre

0.27

114

(3033923) Metanephrine [Moles/time] in 24 hour Urine

119

6.29

52.78

1.1

0.69

12.33

umol/24h

0.49

(3022621) pH of Urine by Test strip

3231

12593

1.37

52.57

2.4

2.1

6.12

6.20

3.92

1976

7691

(3010838) Calcium [Moles/time] in 24 hour Urine

763

2114

1.90

52.28

2.1

5.22

5.56

mmol/24h

1.95

700

1943

(3039162) Centromere protein B Ab [Units/volume] in Serum

723

1972

1.93

51.86

1.3

1.2

49.78

46.41

u/ml

0.10

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1420

4715

1.59

51.84

2.1

1.9

—

(3008898) HLA-B27 [Presence]

2285

8417

1.44

51.35

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

798

2267

1.86

50.73

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

798

2268

1.85

50.66

1.3

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

739

2050

1.90

50.47

1.1

98.26

94.68

2.77

705

1914

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1321

4344

1.61

50.17

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1635

12505

0.67

50.14

1.4

1.5

1.16

1.17

ratio

0.10

958

7517

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1641

12540

0.67

50.10

1.4

1.5

0.96

0.95

ratio

0.72

964

7554

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1641

12540

0.67

50.10

1.4

1.5

1.15

1.19

ratio

0.73

971

7618

(3022493) Free Hemoglobin [Mass/volume] in Plasma

260

446

3.06

50.05

7.6

1.5

610.12

4938.71

mg/l

2.10

217

282

(4034850) Laboratory test

1213

3911

1.64

49.82

9.6

5.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

3728

14974

1.33

49.71

1.4

19.49

22.99

iu/l

10.20

3162

12666

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

337

676

2.62

49.43

1.7

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3846

15547

1.32

49.02

2.6

2.1

11.42

13.44

nmol/l

39.10

3519

14483

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1290

4242

1.61

48.99

1.9

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1316

4358

1.60

48.56

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1764

13195

0.68

47.99

1.5

63.51

62.47

ug/l

0.25

1449

11117

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1616

12284

0.67

47.92

1.4

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1897

6835

1.47

47.72

1.6

1.7

9.73

12.67

u/ml

2.03

462

2104

(42529406) Shigella sp [Presence] in Stool by Culture

1318

4386

1.59

47.66

1.2

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

607

1605

1.99

47.53

3.3

2.3

7.62

6.81

mmol/l

5.36

584

1578

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1317

10353

0.65

46.24

1.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2729

10569

1.37

45.95

1.2

1.1

195.55

180.29

titre

0.11

340

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

506

1266

2.10

45.84

1.9

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2178

15580

0.72

45.66

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

115

109

5.52

45.59

1.3

1.7

141.05

113.66

mu/l

0.16

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1352

10520

0.66

45.10

1.5

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

442

1054

2.20

45.03

1.9

1.6

1676083.13

1581810.03

iu/ml

0.06

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1385

4727

1.55

44.93

2.0

1.8

188.54

207.56

pmol/l

6.32

1324

4571

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

26.15

43.89

4.5

2.9

—

(3005033) Fetal Nuchal fold Thickness US

1297

10120

0.66

43.84

1.5

1.26

0.17

920

7490

(3003434) Protein [Mass/volume] in Pleural fluid

335

714

2.46

43.68

1.6

1.3

32.75

39.35

g/l

14.12

302

673

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

684

1945

1.85

43.40

1.7

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5763

24872

1.24

43.32

3.7

3.5

21.55

20.74

2.92

2253

9808

(3000012) Reticulocyte production index

434

1045

2.18

43.23

2.2

2.4

0.92

0.88

0.61

293

632

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

825

7089

0.60

43.05

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

348

764

2.39

42.68

1.6

1.4

6.26

5.47

u/l

0.81

302

658

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

528

1387

2.00

42.15

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

211

355

3.12

41.98

2.4

1.8

8.13

7.24

mmol/l

2.06

211

355

(3000093) Morphology [Interpretation] in Blood Narrative

407

969

2.21

41.66

1.2

1.1

—

(3017569) Oxygen content in Arterial blood

190

301

3.31

41.42

2.2

16.46

16.47

0.01

190

301

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1047

3416

1.62

41.05

1.8

1.6

413.76

380.62

mu/l

0.92

871

2814

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1899

7041

1.43

41.04

2.0

1.7

36.69

42.85

nmol/l

18.84

1863

6962

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

237

435

2.86

40.90

1.5

1.4

14.39

13.32

pmol/l

1.34

203

375

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

380

890

2.24

40.43

1.8

136.21

123.63

2.65

366

848

(3049717) Cytology report of Urine Cyto stain

927

2944

1.66

40.37

2.4

2.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

371

864

2.25

40.00

1.5

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

371

864

2.25

40.00

1.5

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

371

864

2.25

40.00

1.5

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

435

1084

2.11

39.88

1.2

75.54

71.32

u/l

0.17

388

953

(3045788) Cell count panel - Pleural fluid

270

544

2.60

39.39

1.5

1.4

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

2718

10770

1.34

39.34

2.1

1.9

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

312

680

2.41

38.91

1.8

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

723

2169

1.75

38.63

1.2

27.14

19.23

u/ml

0.39

102

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

505

1369

1.94

37.00

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

7.74

36.94

7.4

6.6

10.97

11.43

0.46

(3002256) Pathology report gross observation

4748

20394

1.24

36.73

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

575

1634

1.85

36.64

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

311

698

2.34

36.47

1.5

1.4

2535.06

4323.55

e6/l

1.52

201

490

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

867

2790

1.64

35.93

1.5

—

(3044927) Protein electrophoresis panel - Urine

264

554

2.50

35.63

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

274

587

2.45

35.47

1.6

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2924

11883

1.31

35.36

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

400

1015

2.07

35.09

3.7

2.7

15.80

14.39

index

0.81

281

632

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

449

1197

1.97

34.52

1.3

180.91

220.00

titre

0.12

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

449

1198

1.97

34.44

1.2

1.3

247.73

225.37

titre

0.16

201

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

587

1720

1.79

33.98

1.2

1.1

34.45

44.28

mg/l

4.37

500

1443

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

570

1669

1.79

33.08

1.1

222.82

249.53

mg/l

1.67

505

1482

(3023419) Bacteria identified in Sputum by Culture

425

1130

1.97

32.95

2.9

3.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

340

831

2.15

32.81

1.1

3.03

4.32

nmol/l

0.23

153

(3007463) Buprenorphine [Presence] in Urine

5.01

32.63

7.0

7.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

258

560

2.42

32.55

1.6

1.3

—

(40768441) Liver Pathology biopsy report

382

983

2.04

32.36

1.6

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

247

527

2.46

32.30

1.6

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

458

1263

1.90

32.01

1.3

1.2

1.87

1.92

mmol/l

0.40

418

1191

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1467

5439

1.42

31.67

1.2

4.42

4.37

0.08

240

971

(3011412) CD3 cells [#/volume] in Blood

559

1653

1.78

31.44

2.4

2.7

1332.85

1318.30

e6/l

0.07

473

1397

(4024509) Urine culture

1596

6020

1.40

31.26

2.0

1.6

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

517

1497

1.81

31.14

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

811

2663

1.60

31.06

1.7

10982.67

11445.47

e6/l

0.11

572

1914

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

566

1689

1.76

30.89

1.4

1.3

5.96

6.09

umol/l

0.31

506

1528

(3013005) Retinol [Moles/volume] in Serum or Plasma

365

940

2.04

30.88

2.2

2.3

1.94

1.83

umol/l

1.46

338

855

(3004616) Nuclear Ab [Presence] in Serum

603

1834

1.73

30.83

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

135

208

3.40

30.79

1.5

1.4

0.22

0.43

mmol/l

0.64

(3041354) Potassium [Moles/volume] in Venous blood

330

819

2.11

30.70

2.4

1.8

4.01

3.98

mmol/l

0.50

325

813

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1093

3851

1.50

30.66

1.4

1.3

18.30

22.09

u/l

3.83

897

3203

(3042111) Morphology [Interpretation] in Bone marrow Narrative

514

1494

1.81

30.59

1.8

1.9

—

(3000330) Specific gravity of Urine by Test strip

1589

6012

1.40

30.58

3.2

2.5

1.02

ratio

0.87

1414

5270

(3035285) Chloride [Moles/volume] in Venous blood

329

819

2.11

30.39

2.4

1.8

105.59

106.03

mmol/l

0.90

324

813

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

748

2422

1.62

30.32

1.1

1.2

1.16

1.09

0.08

188

(3036782) Glucose [Moles/volume] in Pleural fluid

287

681

2.21

29.79

1.4

1.2

6.42

5.37

mmol/l

8.43

265

623

(40759836) Histone Ab [Presence] in Serum by Immunoblot

504

1469

1.80

29.75

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

502

1462

1.80

29.71

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

502

1466

1.80

29.45

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

537

1604

1.76

29.24

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

232

508

2.39

28.81

1.4

1.2

328.73

732.13

u/l

4.18

222

477

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

462

1324

1.83

28.80

2.3

11.91

13.87

4.10

454

1300

(3019420) Tryptase [Mass/volume] in Serum or Plasma

411

1134

1.90

28.74

1.4

1.5

6.43

7.42

ug/l

0.56

373

1033

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1624

6237

1.37

28.58

1.6

17.58

3.57

iu/ml

0.51

258

1094

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

485

1417

1.80

28.43

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1651

11475

0.74

28.24

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

471

1368

1.81

28.15

1.1

—

(1175426) CD3 cells/Lymphocytes in Blood

474

1380

1.80

28.11

2.3

2.4

73.54

73.67

0.05

462

1346

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2495

10229

1.29

28.09

1.4

1.3

219.14

232.42

miu/ml

0.99

1108

5240

(3034988) Calcium [Moles/volume] in Capillary blood

113

164

3.61

28.04

5.0

3.6

1.20

mmol/l

0.18

106

153

(3014148) Varicella zoster virus Ab [Titer] in Serum

969

3394

1.50

27.99

1.2

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

313

790

2.08

27.96

2.4

3.8

90.83

127.35

nmol/l

0.64

303

780

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

262

615

2.23

27.93

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

115

170

3.54

27.84

1.4

1.1

12.48

4.49

pmol/l

1.92

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

316

802

2.07

27.84

1.3

1.2

67.23

78.05

1.04

(4027681) Cerebrospinal fluid IgG ratio and IgG index

460

1331

1.81

27.83

1.2

1.3

0.59

0.70

ratio

4.35

277

762

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

324

833

2.04

27.60

1.1

—

(3023410) Appearance of Cerebral spinal fluid

590

1845

1.68

27.37

1.6

1.8

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

270

648

2.18

27.33

1.8

159.73

132.34

4.31

259

606

(21491868) Cryoglobulin [Mass/volume] in Serum

210

450

2.44

27.31

1.2

0.13

0.36

g/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

314

804

2.05

27.05

2.5

1.8

1.20

mmol/l

0.67

309

798

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

477

1411

1.77

26.88

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

262

630

2.18

26.42

1.5

1.4

29392.56

48361.74

e6/l

0.86

137

371

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

260

624

2.18

26.34

1.2

1.3

96.97

89.35

u/l

0.33

226

536

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

256

614

2.19

25.99

1.2

1.3

23.63

19.71

u/l

0.39

221

520

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

450

1322

1.79

25.96

2.8

3.6

4.29

8.02

nmol/l

0.42

430

1284

(3001019) Free T4 and TSH panel - Serum or Plasma

2931

12377

1.26

25.90

1.7

1.6

—

(3042631) Mycobacterium sp identified in Specimen

381

1063

1.88

25.84

2.4

2.5

—

(3018333) Ribosomal P Ab [Presence] in Serum

464

1378

1.77

25.83

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

403

1147

1.84

25.73

3.2

3.3

55.15

54.13

0.41

363

986

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1611

6287

1.35

25.63

1.4

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

146

267

2.86

25.58

5.4

2.7

10.69

11.15

kpa

0.95

146

267

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

146

267

2.86

25.58

5.4

2.7

4.87

4.86

kpa

0.03

146

267

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

110

170

3.39

25.07

4.7

3.7

1.20

mmol/l

0.04

101

158

(3003694) ABO and Rh group [Type] in Blood

12552

60090

1.13

24.99

1.6

1.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

258

632

2.14

24.91

1.2

0.30

0.29

g/l

2.39

213

502

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

419

1220

1.80

24.91

1.4

11.84

10.32

umol/l

4.59

394

1164

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

246

591

2.18

24.90

1.2

108.91

108.29

0.12

218

547

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

351

965

1.91

24.89

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

266

661

2.11

24.79

1.3

1.2

111.27

108.61

0.36

244

593

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2052

8336

1.30

24.72

1.5

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

261

646

2.12

24.58

1.1

93.57

95.65

0.43

131

281

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

436

1293

1.77

24.42

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

161

320

2.63

24.33

1.7

1.6

9.15

9.05

ug/l

0.09

161

320

(3026692) Albumin [Mass/volume] in Peritoneal fluid

105

161

3.41

24.22

1.4

1.2

13.67

14.45

g/l

0.27

110

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

129

227

2.97

24.13

1.8

1.5

11714.29

403522.73

u/ml

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

439

1311

1.76

24.03

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

291

759

2.01

23.94

1.1

—

(3047189) Immunofixation for 24 hour Urine

139

259

2.81

23.62

1.6

2.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

206

470

2.30

23.52

2.1

1.5

22512.54

2443.79

u/ml

0.60

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

245

602

2.13

23.52

1.7

1.6

6.70

5.60

u/l

0.56

203

474

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

467

1432

1.71

23.34

1.2

1.3

59.75

42.16

u/ml

0.43

(4035726) Immunohistochemistry procedure

2751

11678

1.25

23.15

1.5

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1277

8955

0.74

23.15

1.4

1.5

56.90

60.50

ug/l

2.32

1277

8955

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

252

633

2.09

22.91

1.3

1.1

95.66

94.46

0.15

130

278

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

431

1300

1.74

22.83

2.5

2.9

191.78

225.33

e6/l

2.74

346

1051

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

309

839

1.93

22.77

1.2

22.55

8.99

u/ml

0.63

(3034426) Prothrombin time (PT)

215

508

2.22

22.69

1.3

1.2

28.97

27.59

1.99

215

508

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

384

1122

1.79

22.63

1.1

1.04

1.13

u/l

1.19

136

462

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

229

557

2.15

22.56

1.6

1.4

12.48

11.29

u/l

1.41

220

543

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

6.04

22.51

8.3

2.8

104.92

99.96

g/l

1.16

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

5.14

22.46

1.1

1.0

1.67

7.39

umol/24h

0.47

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

397

1175

1.77

22.43

1.2

1.1

1.05

1.06

ratio

0.84

339

972

(3029075) Extractable nuclear Ab panel - Serum

368

1066

1.81

22.31

1.1

0.17

0.32

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

301

817

1.93

22.22

2.4

27.38

27.96

umol/l

0.40

287

760

(40768806) Pleura Pathology biopsy report

244

614

2.08

22.10

1.6

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

335

946

1.86

22.00

2.7

2.3

—

(44806420) Estimation of glomerular filtration rate

589

1950

1.59

21.96

2.4

1.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

175

383

2.39

21.90

2.7

2.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

258

671

2.01

21.46

2.4

3.1

1.44

1.16

ug/l

1.00

241

637

(3023487) Leukocytes [#/volume] in Peritoneal fluid

134

262

2.68

20.96

2.6

1.6

777.12

3233.50

e6/l

0.71

152

(3026389) Candida sp identified in Specimen by Organism specific culture

725

2544

1.50

20.88

1.3

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

3918

23900

0.84

20.85

1.6

1.5

3.44

3.54

mmol/l

5.23

2682

15403

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

124

234

2.77

20.68

1.3

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

243

627

2.03

20.66

1.3

1.2

358.98

379.25

u/l

0.09

227

589

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

+∞

20.65

9.2

0.0

44.07

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1442

5721

1.33

20.58

1.2

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

10094

48124

1.13

20.58

1.9

1.8

—

(3017704) Immunofixation for Urine

153

324

2.47

20.53

1.5

2.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2875

12426

1.22

20.42

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

131

3.43

20.11

2.5

2.2

193.65

158.22

ug/g

0.90

116

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

182

423

2.25

20.02

3.7

2.8

0.98

1.30

1.79

182

423

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

181

422

2.25

19.78

1.4

1.3

130.31

131.41

nmol/l

0.02

137

317

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

449

1427

1.65

19.76

1.2

1.3

2.19

3.35

u/ml

1.09

247

863

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

391

1198

1.71

19.69

1.2

1.3

59.50

49.70

u/ml

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

175

405

2.26

19.45

1.3

1.2

10.67

17.72

u/l

7.62

160

385

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

407

1270

1.68

19.21

2.4

2.8

540.83

556.82

e6/l

0.14

314

987

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

303

867

1.83

19.18

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

416

1310

1.67

18.98

1.2

114.09

120.74

pmol/l

1.96

416

1310

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

200

495

2.12

18.97

2.0

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

200

495

2.12

18.97

2.0

1.7

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

315

917

1.80

18.89

1.5

1.2

79.83

73.09

umol/l

1.29

315

917

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2570

11088

1.22

18.54

3.9

4.6

17.90

31.68

ug/l

1.30

1983

8391

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

102

184

2.90

18.44

1.3

1.1

1.19

1.18

mmol/l

1.31

102

184

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

265

738

1.88

18.26

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

143

311

2.41

18.23

1.4

1.8

1.20

1.18

nmol/l

—

(40768443) Skin Pathology biopsy report

1586

6487

1.29

18.16

1.2

—

(21494815) CD4 cells/Lymphocytes in Specimen

484

1605

1.58

18.03

2.4

2.5

41.05

38.95

2.07

476

1587

(3006245) CD3-CD19+ cells/cells in Blood

302

881

1.80

18.02

2.9

2.7

12.20

9.34

2.05

291

847

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.02

17.99

1.2

1.1

0.26

0.93

u/ml

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

220

577

2.00

17.99

1.2

74.18

72.89

u/l

0.11

202

517

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

291

840

1.82

17.96

1.9

1.8

4.07

2.70

mg/l

4.49

279

809

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

114

223

2.67

17.90

2.3

1.5

20624.22

12711.74

e6/l

0.18

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1440

5829

1.30

17.84

1.1

5.91

4.84

eliau/ml

0.41

188

944

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.37

17.69

7.1

2.7

—

(3013637) Mi-2 Ab [Presence] in Serum

133

284

2.45

17.63

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

133

284

2.45

17.63

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

133

284

2.45

17.63

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

133

284

2.45

17.63

1.1

—

(3036180) Methadone [Presence] in Urine

5.12

17.58

3.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

218

575

1.99

17.57

1.2

18.61

17.13

u/l

0.24

200

510

(3028717) Thiamine [Mass/volume] in Blood

181

2.86

17.52

1.4

1.2

64.51

60.82

ug/l

0.72

181

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

181

2.86

17.52

1.4

1.5

67.51

77.89

ng/l

0.12

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

510

1726

1.55

17.43

1.4

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

165

2.95

17.31

1.5

1.2

58.29

58.34

0.00

138

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

174

2.89

17.25

2.0

1.9

94054.57

409161.36

nmol/l

0.94

142

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

123

257

2.50

17.05

2.0

2.9

0.79

1.86

mmol/l

4.13

204

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

110

217

2.65

17.03

1.3

1.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

245

681

1.88

17.02

3.2

1.5

53.02

285.42

ug/l

0.99

232

650

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

275

796

1.81

16.86

1.0

1.1

95.58

93.17

0.62

224

630

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1034

4026

1.35

16.80

1.1

15.37

15.91

au/ml

0.10

282

1272

(3010503) CD19 cells [#/volume] in Blood

299

891

1.76

16.67

2.5

2.8

358.09

174.78

e6/l

0.66

293

878

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

4.73

16.62

7.2

9.8

66.13

62.09

0.27

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1888

7976

1.25

16.55

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1269

5102

1.31

16.55

1.6

1.5

0.37

0.45

nmol/l

2.47

1002

4143

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

498

1698

1.54

16.50

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

209

556

1.97

16.49

1.2

1.1

5.67

7.96

u/ml

0.34

(3035880) pH of Pleural fluid

124

265

2.45

16.45

1.3

1.2

7.40

7.36

0.96

179

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

552

1926

1.50

16.45

3.3

3.4

35.17

355.32

u/ml

1.22

545

1906

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

211

565

1.96

16.35

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

472

1595

1.55

16.27

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

478

1620

1.55

16.27

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4270

19493

1.16

16.21

2.8

2.7

0.68

0.72

ug/l

1.57

2414

10202

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1966

8367

1.24

16.13

2.0

1.4

4.65

3.36

mg/l

3.78

1582

5457

(3024522) Salmonella sp identified in Specimen by Organism specific culture

496

1699

1.53

16.11

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

144

3.01

16.06

1.4

1.3

27.72

27.26

g/l

0.07

105

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

329

1019

1.69

16.05

1.4

567.98

501.11

mu/l

0.55

315

971

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

477

1621

1.54

16.05

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

275

809

1.78

16.03

2.3

2.5

28.16

28.77

0.31

268

785

(3044007) Cell count panel - Peritoneal fluid

111

229

2.54

15.82

2.3

1.6

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

161

394

2.14

15.81

1.2

1.1

81.80

94.12

1.53

(3025468) Yersinia sp identified in Specimen by Organism specific culture

474

1615

1.54

15.78

1.4

1.5

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

333

1041

1.68

15.72

1.4

73.54

73.13

0.21

319

993

(3010144) Erythrocytes [#/volume] in Synovial fluid

310

953

1.70

15.56

1.4

1.5

113429.45

63816.82

e6/l

0.65

218

615

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

204

550

1.94

15.54

1.4

1.5

21.75

20.70

u/ml

0.12

(3037692) Legionella sp identified in Specimen by Organism specific culture

141

329

2.24

15.50

1.7

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

162

401

2.11

15.48

1.2

1.1

74.29

79.61

0.40

(3038026) Centromere Ab [Units/volume] in Serum

331

1038

1.67

15.45

1.2

1.3

51.14

41.26

u/ml

0.24

(3020393) Adenovirus Ag [Presence] in Stool

113

239

2.47

15.34

2.0

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

254

741

1.80

15.25

2.7

2.4

0.17

0.28

e9/l

1.13

138

338

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

162

404

2.10

15.20

2.2

2.1

1.80

1.65

ratio

0.61

157

393

(37208534) Antinuclear antibody arbitrary concentration in serum

213

588

1.90

15.17

1.1

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

122

3.13

15.01

1.4

1.2

29.57

26.34

0.34

114

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

6.13

14.98

1.7

1.6

195.50

220.64

nmol/l

0.20

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

169

432

2.05

14.90

1.3

105.54

102.55

0.52

163

402

(1761482) Bacteria [#/volume] in Urine by Culture

626

2288

1.44

14.82

3.8

2.9

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

180

474

1.99

14.67

1.2

1.3

19.54

12.61

0.59

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

235

681

1.81

14.45

2.8

2.7

51.07

49.59

umol/l

0.31

216

625

(3035947) Staphylolysin Ab [Units/volume] in Serum

209

585

1.87

14.31

1.1

4.19

3.76

iu/ml

0.26

(44813793) Dust mix specific IgE antibody measurement

431

1471

1.54

14.29

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

5267

30645

0.88

14.21

1.9

1.7

3.66

3.43

ratio

19.15

3966

22195

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

204

2.54

14.20

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

211

596

1.85

14.07

1.6

1.5

3.04

2.40

u/field

0.33

160

431

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

150

376

2.09

13.94

1.1

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

134

2.93

13.90

1.5

1.2

2.42

4.86

1.17

117

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

6.23

13.86

1.8

1.4

300.15

233.32

nmol/l

0.21

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

779

2996

1.36

13.78

1.1

2.88

2.75

0.11

168

589

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

464

1625

1.50

13.68

4.6

5.0

79.55

100.01

u/ml

0.32

142

616

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

261

794

1.72

13.67

1.2

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

189

521

1.90

13.58

1.4

1.2

1418.89

112.73

titre

—

(3019832) Treponema pallidum Ab [Presence] in Serum

7321

41697

0.90

13.52

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

995

3983

1.31

13.47

3.3

4.1

4095.43

2453.28

u/ml

0.22

867

3448

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

210

601

1.83

13.47

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

184

506

1.90

13.32

1.4

1.2

56.36

90.36

titre

0.60

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

203

578

1.84

13.24

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

304

973

1.64

13.22

1.7

1.6

33.60

39.40

1.58

190

634

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

570

2101

1.42

12.96

1.1

2.70

2.25

iu/ml

—

(3018133) Calcium [Moles/volume] in Urine

156

409

2.00

12.93

2.3

2.5

2.87

2.73

mmol/l

0.29

141

386

(3020717) Zinc [Moles/volume] in Serum or Plasma

336

1112

1.58

12.79

1.7

22.04

24.11

umol/l

0.65

316

1037

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

145

372

2.04

12.74

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

181

503

1.88

12.73

1.4

17.06

16.04

umol/l

1.28

159

424

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

205

594

1.81

12.68

1.3

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

5.81

12.66

3.1

2.7

2.32

2.76

ug/l

0.35

(3047007) Chlamydophila sp Ab [Presence] in Serum

828

3261

1.33

12.59

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

231

696

1.74

12.56

1.7

2860.00

2803.33

titre

0.03

114

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

445

3347

0.69

12.54

1.4

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

190

540

1.84

12.50

1.2

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

207

605

1.79

12.46

2.2

28.87

30.96

1.28

207

605

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

133

334

2.08

12.37

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

245

758

1.69

12.15

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

215

641

1.76

12.13

1.1

110.75

176.04

ng/l

0.46

162

(3006571) Granulocytes/Leukocytes in Synovial fluid

379

1306

1.52

12.12

1.7

1.6

55.67

48.93

2.17

234

869

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

649

2477

1.37

12.10

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

259

816

1.66

12.02

2.1

1.7

1.66

4.88

u/field

0.60

156

461

(3033099) Centromere Ab [Titer] in Serum

131

331

2.07

12.01

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

3.61

11.96

1.1

1.4

25.12

18.16

u/ml

0.44

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

551

2052

1.41

11.88

1.4

1.6

8.64

6.88

mmol/l

18.87

532

2020

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

139

361

2.01

11.87

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

336

1133

1.55

11.86

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

380

1318

1.51

11.81

2.3

1.8

20.80

26.22

mg/l

1.46

150

469

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

130

2.78

11.75

1.2

1.3

51.09

45.57

mg/l

0.42

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

285

926

1.61

11.75

4.5

4.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

145

384

1.98

11.75

1.1

—

(3028433) Virus identified in Specimen by Culture

157

428

1.92

11.73

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

341

1158

1.54

11.67

2.9

2.1

25.55

27.33

mg/l

0.39

250

783

(3017509) Phencyclidine [Presence] in Urine

131

335

2.05

11.66

2.7

1.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

763

3006

1.33

11.62

1.8

1.9

5491.20

2635.33

titre

0.68

137

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

202

601

1.76

11.51

1.7

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

202

601

1.76

11.51

1.7

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

202

601

1.76

11.51

1.7

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

202

604

1.75

11.33

1.6

2.0

—

(3033942) Copper [Moles/time] in 24 hour Urine

3.21

11.03

1.2

1.4

0.84

0.98

umol/24h

0.09

(3045142) Bone marrow Pathology biopsy report

360

1254

1.50

11.01

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

348

1209

1.51

10.78

2.5

2.8

0.76

0.75

e9/l

0.13

340

1179

(46235355) HIV 1 and 2 tests - Meaningful Use set

12111

59793

1.08

10.55

2.3

2.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

107

265

2.11

10.39

1.0

1.1

79.77

77.85

ug/l

0.17

219

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

118

305

2.02

10.28

1.7

2.5

40.88

41.69

g/l

0.72

118

305

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

3.07

10.15

1.5

1.4

8.87

9.13

pmol/l

0.04

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

190

2.31

10.08

2.1

1.5

—

(3000285) Sodium [Moles/volume] in Blood

136

2.58

10.03

1.2

1.1

138.37

139.29

mmol/l

1.04

115

(21494434) Karyotype in Bone marrow

261

865

1.58

10.01

1.2

1.3

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

184

557

1.73

9.96

1.4

1.6

6.02

5.74

nmol/l

0.40

175

537

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.35

9.94

1.6

1.3

469.57

629.13

nmol/l

0.82

(3006270) Folate [Moles/volume] in Blood

283

961

1.54

9.79

1.1

397.75

395.58

nmol/l

0.06

264

882

(3051387) C reactive protein [Mass/volume] in Capillary blood

723

2909

1.30

9.58

3.8

2.6

21.15

26.46

mg/l

4.63

504

1862

(3004716) Salmonella sp identified in Stool by Organism specific culture

2530

11548

1.15

9.55

1.4

—

(44806071) Cardiolipin IgM antibody measurement

102

258

2.07

9.44

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

125

341

1.92

9.43

1.1

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

847

3492

1.27

9.31

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

161

2.37

9.29

1.2

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.48

9.28

1.1

24.60

26.50

u/l

0.12

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

5.75

9.24

1.4

1.2

166.83

93.35

ug/l

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

229

2.12

9.22

1.2

1.3

1.55

1.74

iu/ml

0.39

117

(40761539) Cells [Type] in Urine sediment by Light microscopy

100

255

2.05

9.08

1.2

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

4.13

9.07

1.5

1.3

127.79

124.44

nmol/l

0.04

(3043410) Blood group antigens tested for on Red Blood Cells

133

377

1.85

8.98

1.6

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

683

2754

1.30

8.94

1.4

1.5

7.16

6.35

mmol/l

11.91

622

2482

(3013166) Neutrophils/Leukocytes in Synovial fluid

100

257

2.03

8.91

1.4

47.19

49.01

0.17

225

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

145

424

1.79

8.88

2.7

3.3

29.30

28.60

umol/l

0.22

102

327

(3014271) Vancomycin [Susceptibility]

111

297

1.95

8.87

2.5

2.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

837

3471

1.26

8.80

1.1

—

(21494755) Public health laboratory ask at order entry panel

4823

27482

0.91

8.60

1.3

—

(3034891) Synovial lining cells/cells in Synovial fluid

171

530

1.69

8.59

1.5

1.6

5.43

4.71

0.17

121

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

427

1616

1.38

8.54

1.2

1.44

1.09

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

239

809

1.55

8.46

1.4

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

135

393

1.80

8.41

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

305

1089

1.47

8.40

1.7

1.4

6.73

5.73

mmol/l

6.05

232

876

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

252

867

1.52

8.30

1.8

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.25

8.14

1.2

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

9.02

8.14

3.6

5.3

2.08

2.74

mg/l

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

147

446

1.72

8.00

1.8

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

147

446

1.72

8.00

1.8

2.2

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

4.48

7.97

4.3

2.5

1275.14

1800.90

umol/l

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

160

2.25

7.94

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

107

295

1.90

7.91

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

147

448

1.72

7.89

1.7

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

524

2079

1.32

7.78

3.7

4.0

673.24

693.90

u/ml

0.01

484

1890

(3022229) Phosphate [Moles/volume] in Urine

182

2.15

7.77

2.6

2.7

22.08

20.72

mmol/l

0.20

168

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.21

7.66

1.5

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.70

7.62

1.2

1.1

—

(3014891) Appearance of Pleural fluid

3.14

7.62

1.8

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1788

10730

0.86

7.59

1.1

0.64

0.63

ratio

0.31

182

1012

(40757373) Influenza virus identified in Isolate

184

2.13

7.58

1.9

1.2

—

(3011436) Histone Ab [Units/volume] in Serum

248

1.96

7.58

1.1

31.00

8.50

u/ml

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

254

895

1.49

7.53

6.8

7.8

139.01

45.32

ug/l

0.56

173

613

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.67

7.48

1.3

1.2

2.62

1.52

mmol/l

0.36

(3023436) Glucagon [Mass/volume] in Serum or Plasma

3.34

7.45

1.8

2.2

192.15

180.73

ng/l

0.41

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

203

2.06

7.45

1.6

1.7

1.63

1.17

mg/l

0.31

124

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

203

2.06

7.45

1.6

1.7

1.31

2.67

mg/l

1.76

141

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

203

2.06

7.45

1.6

1.7

1.79

1.86

mg/l

0.04

138

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

203

2.06

7.45

1.6

1.7

2.30

2.85

mg/l

0.31

154

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

203

2.06

7.45

1.6

1.7

1.75

2.36

mg/l

0.45

153

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

203

2.06

7.45

1.6

1.7

4.14

4.35

mg/l

0.08

132

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

203

2.06

7.45

1.6

1.7

0.55

1.00

mg/l

1.08

146

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

203

2.06

7.45

1.6

1.7

2.16

3.21

mg/l

0.96

146

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

203

2.06

7.45

1.6

1.7

1.66

1.51

mg/l

0.12

152

(37019676) Renin [Units/volume] in Plasma --supine

14.63

7.40

1.4

1.0

40.46

30.76

mu/l

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

186

2.11

7.40

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

146

454

1.68

7.33

1.8

2.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

208

2.04

7.32

1.6

1.7

1.60

1.64

mg/l

0.03

137

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

3.10

7.29

1.7

1.3

11.35

11.55

0.02

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1848

8419

1.15

7.23

1.6

1.5

—

(40765096) Chromosome analysis panel by Banding

112

324

1.81

7.20

1.1

1.2

—

(3024263) Appearance of Synovial fluid

160

513

1.63

7.17

1.8

2.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

121

359

1.76

7.16

3.7

3.9

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

186

2.08

7.08

1.0

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

143

447

1.67

7.06

1.3

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

130

396

1.72

7.04

1.1

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

5963

29020

1.09

7.03

2.4

2.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

208

2.01

7.02

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

143

448

1.67

7.01

1.3

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

8526

42091

1.07

6.91

2.4

2.3

—

(3050794) Legionella sp Ab [Presence] in Serum

104

2.46

6.86

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

258

931

1.45

6.84

2.7

3.0

44.41

40.96

2.20

153

466

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5016

24263

1.09

6.82

2.2

2.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.53

6.79

1.3

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

179

2.07

6.76

2.6

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2036

9387

1.14

6.72

2.7

2.9

37.31

43.71

u/ml

0.88

1969

9117

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.48

6.68

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.80

6.64

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.65

6.59

2.1

2.2

248.80

240.70

ug/l

0.09

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

177

597

1.55

6.49

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.35

6.48

1.1

1.2

—

mmol/l

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

101

2.43

6.44

1.3

1.2

1.78

2.10

mmol/l

0.65

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

152

2.13

6.35

1.1

1.0

0.03

0.05

u/ml

0.58

152

(3001556) Androgen free Index in Serum or Plasma

110

330

1.74

6.33

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.99

6.33

1.0

15.67

2.71

iu/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

160

2.09

6.26

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

111

954

0.61

6.21

1.2

64.99

67.67

ug/l

0.23

111

954

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

133

2.20

6.19

2.3

2.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

166

2.05

6.03

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

9204

45744

1.07

6.01

2.5

2.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

221

1.89

5.99

1.8

2.1

31.45

29.59

pmol/l

0.09

186

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.78

5.98

1.4

1.3

31.24

537.48

u/l

0.62

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

127

1046

0.63

5.93

6.8

6.5

8.43

8.78

0.28

127

1046

(3002619) Bacteria identified in Specimen by Culture

113

349

1.69

5.91

1.2

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

127

1045

0.63

5.91

3.4

3.2

43.72

45.20

0.33

127

1045

(3003740) Influenza virus B Ag [Presence] in Specimen

1191

5334

1.17

5.90

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

126

2.20

5.87

1.9

7.83

6.76

mmol/l

0.57

(3002523) Influenza virus A Ag [Presence] in Specimen

1189

5340

1.17

5.70

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.90

5.70

1.9

2.0

38.43

46.41

umol/l

1.10

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

454

1850

1.28

5.68

1.1

13.82

17.62

u/ml

1.97

194

814

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

252

1.80

5.67

1.4

1.3

35.02

46.19

1.74

173

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

102

2.31

5.56

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

231

1.83

5.55

1.3

1.2

217.02

94.07

mg/l

0.61

154

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

158

2.02

5.50

1.2

1.0

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.36

5.46

2.5

4.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

159

2.01

5.41

1.1

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

272

1.75

5.38

2.7

2.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

411

1667

1.29

5.36

1.1

8.52

7.29

iu/ml

0.44

120

502

(3052592) Norovirus Ag [Presence] in Stool

164

1.98

5.30

1.6

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

217

1.83

5.21

1.1

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

102

2.25

5.20

3.1

3.5

27.16

753.02

pmol/l

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

2.45

5.20

1.3

0.95

2.59

ml/s/173m2

1.25

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

144

2.03

5.17

1.8

1.7

—

(3013466) aPTT in Blood by Coagulation assay

116

2.16

5.16

1.1

35.02

37.16

1.90

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

123

2.12

5.16

3.0

3.1

1.29

1.54

mg/l

0.24

(3010015) Selenium [Moles/volume] in Serum or Plasma

245

1.77

5.13

2.0

2.2

1.27

1.25

umol/l

0.16

176

(3025549) Creatine [Moles/time] in 24 hour Urine

2.70

5.08

1.4

1.5

—

13.37

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

156

1.98

5.07

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.48

5.00

1.2

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

147

1.99

4.91

1.2

47.83

414.68

ug/l

1.69

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

199

1.84

4.89

1.2

1.3

0.68

0.46

iu/ml

0.51

(3019174) dRVVT (LA screen)

151

1.97

4.88

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

215

1.80

4.84

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

397

0.47

4.83

1.0

1.1

1.21

1.16

mom

0.19

397

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.41

4.78

1.1

83.27

53.17

u/l

0.38

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

156

1.94

4.77

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.31

4.76

1.1

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

+∞

4.76

5.8

0.0

—

(3032057) Clostridioides difficile [Presence] in Stool

172

1.88

4.68

2.0

1.9

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

141

490

1.50

4.66

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

141

491

1.50

4.62

1.2

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.70

4.60

1.0

1.1

3.06

3.13

0.03

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

115

2.09

4.60

2.5

3.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

182

1325

0.72

4.57

2.9

3.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

202

1445

0.73

4.54

1.0

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.53

4.53

1.0

0.35

0.66

u/ml

0.35

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

141

1.96

4.52

1.0

1.1

—

(3033086) Enterovirus Ab [Titer] in Serum

2.85

4.48

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

217

1.76

4.47

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

140

491

1.49

4.45

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1434

6653

1.13

4.42

1.2

1.1

2.29

2.49

u/ml

0.29

780

3649

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

528

2262

1.22

4.39

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

185

1.81

4.30

1.1

373.60

327.35

u/ml

0.16

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.48

4.25

1.0

0.02

0.11

u/ml

1.25

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.63

4.25

1.1

1.2

27.11

35.23

umol/24h

0.66

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.61

4.19

1.1

0.20

0.21

g/l

0.14

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

135

477

1.48

4.17

2.6

3.4

2.04

1.75

ratio

1.22

129

434

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.48

4.10

1.1

1.0

0.04

0.19

u/ml

0.52

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

231

1.70

4.10

1.1

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

251

1.67

4.09

1.0

1.1

0.15

1.25

u/ml

4.31

157

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.25

4.07

4.3

5.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.19

4.05

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

151

1.87

4.04

3.6

4.2

44.71

43.53

umol/l

0.12

125

(3028679) Herpes simplex virus Ab [Presence] in Serum

367

1527

1.26

4.02

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

520

3263

0.83

4.01

1.6

8.04

7.40

mmol/l

8.66

496

3144

(3027570) Oxalate [Moles/time] in 24 hour Urine

104

2.06

4.00

1.6

1.4

318.56

293.37

umol/24h

0.35

104

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

153

1.84

3.89

1.3

47.36

63.07

1.40

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

2.81

3.87

2.3

1.3

19.23

32.06

0.60

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.34

3.82

1.1

86.88

91.18

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

172

1223

0.73

3.80

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

133

479

1.45

3.78

1.0

1.1

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

2.51

3.78

1.4

71.15

73.17

0.10

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.17

3.77

2.2

2.6

3.33

1.99

mu/l

0.41

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

267

1082

1.29

3.66

1.4

1.5

5.52

5.10

mmol/l

4.91

250

1037

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

287

1175

1.28

3.64

2.1

2.2

20.32

25.53

ug/l

1.75

281

1160

(3044009) aPTT.lupus sensitive (LA screen)

165

1.77

3.60

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.56

3.60

1.3

38.83

27.80

mg/24h

1.49

(3024316) Viscosity of Plasma

2.38

3.56

1.0

2.1

1.29

1.88

mpas

2.51

(3030313) Adrenal Ab [Titer] in Serum

278

1.58

3.54

1.1

1.2

35.00

40.87

titre

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

2.46

3.50

2.3

1.4

52.87

56.42

0.16

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.04

3.49

1.1

17.83

10.08

u/l

0.50

(3007542) Rye IgE Ab [Units/volume] in Serum

153

1.78

3.38

1.0

1.1

0.45

14.42

u/ml

0.51

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

215

857

1.31

3.36

1.1

11.56

12.79

u/ml

0.14

164

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1204

5631

1.12

3.35

1.1

1.37

1.11

u/ml

0.45

540

2699

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

185

1.69

3.34

2.0

1.9

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

213

1.64

3.33

3.7

2.5

5.55

5.36

0.03

(3003888) Timothy IgE Ab [Units/volume] in Serum

1258

5902

1.12

3.32

1.1

5.64

6.43

u/ml

0.90

691

3385

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

139

1.80

3.29

1.0

1.1

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

2.61

3.28

1.1

1.0

0.02

0.04

u/ml

0.67

(3007456) Orange IgE Ab [Units/volume] in Serum

2.26

3.22

1.0

0.05

0.28

u/ml

0.67

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

774

3530

1.15

3.21

1.1

3.11

3.04

eliau/ml

0.05

369

1851

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

125

1.84

3.21

1.0

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

212

1.63

3.18

1.2

1.4

35.68

43.42

mg/l

0.68

181

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

2.13

3.15

1.3

1.5

20.04

14.20

0.40

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

925

4276

1.13

3.15

1.5

1.4

113.07

90.32

pmol/l

0.58

902

4159

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.32

3.14

1.8

2.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.55

3.14

1.3

1.5

2.35

2.02

g/l

0.47

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

106

382

1.45

3.08

1.1

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

5.22

3.07

3.3

7.4

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.05

3.06

1.0

0.05

0.17

u/ml

0.63

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.19

3.01

1.0

0.10

0.08

u/ml

0.06

(3026051) Granulocytes/Leukocytes in Pleural fluid

132

1.78

3.00

1.4

1.3

28.26

21.98

0.62

107

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.98

2.99

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

252

1045

1.26

2.96

1.4

1.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

156

1.71

2.96

2.7

3.1

51.50

50.18

pmol/l

0.05

125

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.69

2.95

1.4

3.80

3.77

mg/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

351

1.46

2.95

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

4.35

2.95

1.1

1.2

160.50

289.08

nmol/l

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

133

1.77

2.93

1.4

1.3

—

(3034614) HLA Ag [Interpretation]

2.39

2.92

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.96

2.91

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.97

2.86

6.2

3.8

7.64

8.14

mmol/l

0.42

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

162

0.39

2.85

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

994

4647

1.12

2.85

1.6

1.5

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

350

1.45

2.83

1.1

1.0

0.02

0.11

u/ml

0.85

212

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

359

1.44

2.82

1.1

1.0

6.12

6.57

u/ml

0.12

359

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

183

1.63

2.79

1.5

16.22

15.97

nmol/l

0.04

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.02

2.78

1.6

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

249

1040

1.25

2.78

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.23

2.78

1.0

0.07

0.01

u/ml

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

4.02

2.76

1.2

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.16

2.72

1.6

1.4

0.00

u/l

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.54

2.68

1.7

1.4

351.53

467.09

mg/24h

0.91

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

122

1.76

2.64

2.6

1.8

0.78

0.73

u/field

0.10

122

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1054

4975

1.11

2.58

1.1

4.99

4.47

u/ml

0.34

547

2604

(3035082) Kappa light chains [Mass/volume] in Urine

3.38

2.56

1.0

1.2

0.03

0.49

g/l

—

(3009992) Blasts/cells in Bone marrow

4.64

2.56

1.9

9.25

11.89

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

4.64

2.56

1.1

0.63

1.44

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

196

1.57

2.55

2.2

1.7

—

(3023383) Lactate [Moles/volume] in Pleural fluid

180

1.60

2.53

1.4

1.2

3.38

4.24

mmol/l

1.08

164

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.09

2.53

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

121

465

1.36

2.52

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

231

1.52

2.48

3.1

5.07

332.28

ug/l

0.51

231

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

287

1.46

2.46

1.5

1.6

0.42

0.41

ug/l

0.13

213

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

266

1137

1.22

2.45

1.2

9.80

7.88

mm/h

2.17

266

1137

(3032868) Hemoglobin electrophoresis panel in Blood

215

1.53

2.45

1.5

1.6

—

(3024869) Neuronal Ab [Presence] in Serum

195

1.55

2.41

1.1

—

(3006598) pH of Arterial cord blood

234

0.54

2.40

1.0

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.46

2.39

1.3

1.2

2.69

1.98

mmol/24h

0.57

(4015189) Microbial culture of sputum

200

1.54

2.37

3.0

2.3

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

2.02

2.35

1.3

0.50

1.82

0.93

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.84

2.35

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

277

1.45

2.35

1.5

1.4

—

(3004959) Base excess in Arterial cord blood by calculation

232

0.54

2.34

1.0

1.1

-1.30

-2.01

mmol/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1203

5752

1.10

2.30

1.1

1.87

2.34

u/ml

1.07

622

3046

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1095

6257

0.91

2.25

1.4

1.3

3.18

3.54

ug/l

1.12

1017

5828

(3007700) Barley IgE Ab [Units/volume] in Serum

137

1.64

2.23

1.0

0.51

11.36

u/ml

0.50

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

280

1217

1.20

2.22

1.5

1.6

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

166

1.57

2.21

1.1

0.63

3.42

u/ml

1.90

117

(3036071) Salmonella sp Ab [Titer] in Serum

171

706

1.27

2.19

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

227

0.55

2.19

1.0

1.1

3.96

3.76

kpa

0.07

193

(3005082) Progesterone [Moles/volume] in Serum or Plasma

423

2549

0.87

2.18

1.4

1.5

26.26

35.76

nmol/l

9.89

377

2392

(3008896) Cortisol [Moles/volume] in Urine

5.22

2.18

1.0

1.2

39.50

68.83

nmol/l

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

219

931

1.23

2.17

2.2

2.3

8.99

9.79

mg/l

1.31

181

771

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.32

2.16

1.3

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

125

497

1.31

2.14

1.5

1.8

0.21

0.23

nmol/l

0.31

372

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

147

1.60

2.14

1.1

86.76

91.21

titre

0.12

147

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.83

2.11

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

152

1.58

2.09

1.7

1.2

365.00

111.26

titre

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

190

1.51

2.07

1.3

1.5

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.90

2.04

1.1

1.07

1.51

mg/l

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

1.78

1.97

1.4

43.64

26.52

1.18

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

889

4232

1.10

1.93

1.1

0.69

0.38

u/ml

0.69

286

1289

(40768795) Lymph node Pathology biopsy report

328

1467

1.17

1.93

1.3

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

1.76

1.90

1.1

22.50

18.04

—

(3006567) Chloride [Moles/time] in 24 hour Urine

3.21

1.90

1.1

1.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

184

782

1.23

1.88

1.2

1.1

54.92

61.85

u/ml

0.68

184

766

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

5.22

1.88

1.0

55.26

28.24

ug/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

159

667

1.25

1.84

1.0

37.31

42.49

ng/l

0.64

103

517

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.85

1.82

1.6

1.3

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

3.92

1.79

1.2

1.0

16.83

22.38

umol/l

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

280

1.38

1.79

1.0

1.1

0.45

7.23

u/ml

0.59

145

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

157

660

1.24

1.79

1.0

269.30

339.70

ng/l

2.18

106

518

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

130

535

1.27

1.78

1.3

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

104

417

1.30

1.74

2.2

2.3

3.37

3.29

ug/l

0.05

383

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

207

1.44

1.74

1.9

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

332

1503

1.15

1.71

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.02

1.71

1.1

1.0

10.51

12.97

mg/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

980

4718

1.09

1.70

1.1

6.10

5.94

u/ml

0.06

461

2251

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.26

1.69

1.2

1.1

1.14

1.11

u/field

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.12

1.69

1.1

1.0

0.04

0.17

u/ml

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.61

1.68

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.61

1.68

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.61

1.68

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.61

1.68

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.61

1.68

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.61

1.68

2.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

248

1.39

1.68

1.4

1.3

38.49

40.77

g/l

0.67

140

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

157

667

1.23

1.66

1.0

822.40

769.27

ng/l

0.64

107

505

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.32

1.65

1.1

1.2

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

1.83

1.63

2.1

1.8

0.46

0.73

0.33

(3025577) Chromium [Mass/volume] in Blood

101

408

1.29

1.62

2.2

3.04

2.43

ug/l

0.38

348

(3009883) Potato IgE Ab [Units/volume] in Serum

2.06

1.60

1.0

0.04

0.57

u/ml

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

208

913

1.19

1.59

1.0

0.43

0.86

u/ml

1.58

203

901

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

227

1005

1.18

1.58

1.0

9.25

12.71

u/ml

1.74

165

670

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

252

1.37

1.56

2.3

1.7

1.69

1.77

mg/l

0.15

212

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.74

1.55

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.93

1.54

11.7

10.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

293

1328

1.15

1.52

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

339

1.31

1.52

1.2

1.3

—

(3001729) Color of Synovial fluid

1.72

1.48

2.1

1.7

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.41

1.47

1.0

177.00

165.87

g/l

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.38

1.44

1.2

29.20

28.58

mg/l

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

146

629

1.21

1.40

1.1

5.62

3.33

u/ml

0.22

126

564

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

423

2462

0.90

1.39

3.8

27.34

37.63

u/ml

1.41

407

2371

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.77

1.37

1.1

1.0

0.07

1.90

u/ml

1.21

(46236302) HLA-C [Type] by High resolution typing

1.69

1.36

1.0

—

(40763590) HLA-DQ beta [Type]

1.69

1.36

1.0

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

2.09

1.34

1.0

1.1

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

2.09

1.34

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

177

781

1.18

1.33

1.3

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

149

1.44

1.31

1.2

1.5

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.46

1.31

1.1

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

102

427

1.25

1.30

2.1

3.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

157

688

1.19

1.28

1.9

1.8

144.90

139.18

au/ml

0.04

(3009677) Dengue virus Ab [Presence] in Serum

111

1.51

1.28

1.2

1.1

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

736

3553

1.08

1.28

2.9

2.0

13.13

13.03

2.02

722

3517

(3009015) Lactate [Moles/volume] in Synovial fluid

1.58

1.27

1.4

1.2

5.74

5.73

mmol/l

0.00

(3018001) Oat IgE Ab [Units/volume] in Serum

199

1.37

1.26

1.0

0.23

0.91

u/ml

0.70

113

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

208

1.36

1.26

1.0

1.37

0.72

u/ml

0.21

196

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.78

1.25

1.3

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

230

0.68

1.25

1.0

—

(4281824) Cell count and differential, peritoneal fluid

323

1501

1.12

1.22

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

293

1723

0.89

1.20

1.5

0.50

0.52

e9/l

0.74

293

1723

(40760410) HLA-B [Type] by High resolution

1.64

1.19

1.0

—

(40760409) HLA-A [Type] by High resolution

1.64

1.19

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.05

1.19

2.4

2.1

25.15

28.68

0.32

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.66

1.18

1.1

0.03

0.76

mg/l

0.51

(3015076) Soybean IgE Ab [Units/volume] in Serum

381

1792

1.11

1.18

1.0

1.1

0.65

1.17

u/ml

0.75

104

485

(3041672) Baker's yeast Ab [Presence] in Serum

158

1.39

1.15

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

420

1991

1.10

1.13

1.0

1.1

0.91

2.92

u/ml

2.88

152

684

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

351

1.25

1.12

1.0

0.63

0.23

u/ml

0.41

210

(3046861) Legionella sp Ag [Presence] in Urine

1.68

1.12

1.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.68

1.12

1.2

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.61

1.10

1.0

1.1

—

(3013931) Oligosaccharides [Presence] in Urine

2.61

1.10

1.0

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.98

1.10

1.2

1.1

5.16

3.65

mmol/l

—

(4212803) Bone marrow aspirate examination

1.61

1.07

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

185

838

1.15

1.06

1.1

3.98

21.26

u/ml

0.95

109

552

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

841

4117

1.07

1.06

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

130

1.41

1.04

1.1

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

1.03

0.0

1.0

—

(3013862) HLA-DP [Type]

1.57

1.03

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.03

0.97

1.1

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

404

1931

1.09

0.96

1.1

2.40

6.19

u/ml

0.83

111

544

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.93

0.95

1.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

210

0.72

0.93

1.1

1.6

0.17

0.44

umol/l

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.53

0.93

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.24

0.93

1.2

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

248

1.26

0.92

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

103

1.42

0.90

1.0

1.1

1.17

1.02

u/ml

0.04

103

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

126

1.37

0.88

1.1

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.87

0.87

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

125

757

0.86

0.87

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.70

0.87

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

387

1858

1.09

0.86

1.7

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.56

0.84

1.1

1.2

1.00

1.14

u/field

1.24

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

1.96

0.82

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1062

5285

1.05

0.82

2.6

2.3

6.18

5.66

umol/l

0.53

786

3923

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.69

0.80

1.0

1.1

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.80

0.80

1.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.74

0.80

1.3

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

216

1.26

0.79

1.0

1.07

2.21

u/ml

0.46

174

(3035153) Lemon IgE Ab [Units/volume] in Serum

2.37

0.79

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

339

1.20

0.79

1.0

1.1

0.05

0.51

u/ml

2.45

167

(3032352) Blasts [#/volume] in Cerebral spinal fluid

193

1.27

0.79

3.7

3.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

285

0.79

0.78

1.3

1.1

6.66

6.55

mmol/l

—

(40758358) Immune stain study

0.57

0.77

1.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

208

1.26

0.76

1.0

1.1

15.93

20.95

u/ml

0.25

167

(3002853) Influenza virus B Ab [Titer] in Serum

2.18

0.76

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.62

0.75

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

894

4446

1.05

0.74

1.9

1.7

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

212

999

1.11

0.73

2.7

3.0

120.50

142.17

au/ml

0.30

158

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.61

0.73

1.1

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

1.47

0.71

1.3

1.2

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.74

0.70

1.1

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.74

0.70

1.0

0.02

0.03

u/ml

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

281

1349

1.09

0.68

1.8

1.9

1.59

2.93

u/ml

1.93

424

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.66

0.67

1.0

—

(3020650) Glucose [Presence] in Urine

143

666

1.12

0.64

1.5

0.08

0.01

estimate

1.08

143

666

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.42

0.63

1.1

1.0

—

(3025130) Human papilloma virus identified in Specimen

905

4528

1.04

0.62

1.9

—

(3013336) Amino acids [Identifier] in Serum or Plasma

103

1.32

0.60

4.8

2.3

—

(3049233) Organic acids panel - Urine

1.44

0.60

1.0

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

269

1.18

0.58

1.3

1.5

5.81

5.31

mmol/l

3.53

269

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.55

0.56

1.0

1.1

0.01

0.55

u/ml

1.29

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.42

0.56

1.1

248.75

301.43

u/ml

0.55

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

338

1653

1.07

0.55

1.4

1.3

183.60

208.41

pmol/l

0.36

338

1653

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

305

1.16

0.54

1.5

2.0

1.90

4.02

ug/l

0.78

199

(40759632) Porphyrins [Mass/mass] in Stool

1.57

0.53

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

376

2082

0.94

0.51

1.8

2.0

2673.72

715.17

pmol/l

0.42

282

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

262

0.84

0.49

1.1

20.89

19.68

mmol/l

1.33

242

(4038314) Semen analysis, post vasectomy

312

0.85

0.48

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.46

0.47

1.1

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

286

1.15

0.46

2.2

2.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

121

574

1.10

0.44

1.0

1.1

33.18

32.03

iu/ml

0.07

121

574

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

1.63

0.44

1.0

1.1

—

(44786800) Granulocytes/Leukocytes in Body fluid

1.35

0.42

1.4

1.2

26.90

33.27

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

205

998

1.07

0.42

1.9

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.31

0.42

1.1

1.0

—

(4211845) Urine protein measurement

160

773

1.08

0.41

2.5

2.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

125

710

0.92

0.38

1.6

2.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.74

0.38

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

135

1.20

0.38

1.7

1.6

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.49

0.37

1.2

1.0

713.33

1961.90

titre

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.36

0.34

1.0

1.1

3683.33

3787.22

titre

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

417

0.90

0.34

1.3

—

(3016135) IgD [Mass/volume] in Serum

1.33

0.32

1.3

1.4

37.88

89.20

mg/l

0.96

(40768800) Prostate Pathology biopsy report

339

1849

0.96

0.32

1.2

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.35

0.32

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

104

0.80

0.31

1.1

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

376

1.10

0.31

1.0

1.1

7.66

2.24

u/ml

0.31

174

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.25

0.31

1.0

4.91

4.32

u/ml

0.05

(3022670) pH of Venous cord blood

0.80

0.30

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

121

588

1.08

0.30

3.1

2.3

129.19

107.36

ng/l

0.31

401

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.34

0.28

4.7

5.6

0.26

0.19

mmol/l

—

(3013762) Body weight Measured

0.79

0.26

1.1

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.81

0.26

6.0

6.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

249

1356

0.96

0.25

1.3

1073.58

1059.70

titre

0.06

263

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.28

0.23

1.3

1.2

203.64

332.44

nmol/l

0.67

(3022475) Manganese [Moles/volume] in Blood

118

1.15

0.23

1.4

1.3

0.15

0.16

umol/l

0.33

118

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

228

1143

1.04

0.22

3.7

3.8

7.55

9.30

mg/l

4.52

185

929

(3010937) Rubella virus Ab [Presence] in Serum

221

0.90

0.22

1.0

1.1

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.22

0.0

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.80

0.21

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

345

1.07

0.20

1.0

1.1

0.18

1.43

u/ml

2.45

247

(3032641) Amino acids panel - Urine

1.25

0.20

1.4

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.18

0.20

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

145

1.12

0.19

1.9

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

292

1.07

0.17

2.3

3.7

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.73

0.17

1.2

1.1

—

346.50

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

252

1.08

0.17

1.1

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.78

0.16

1.0

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

102

1.13

0.15

1.2

1.0

0.08

0.81

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

376

1.06

0.15

1.0

1.1

0.01

0.96

u/ml

2.03

182

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.16

0.14

5.1

6.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

287

1535

0.98

0.13

1.2

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.14

0.12

1.6

1.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

183

931

1.03

0.11

7.0

7.3

16988.95

1231.32

u/ml

0.46

193

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

212

1.06

0.10

1.1

30.50

22.20

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

212

1.06

0.10

1.1

24.71

33.57

u/ml

0.44

(3011841) English Walnut IgE Ab [Units/volume] in Serum

376

0.96

0.10

1.0

1.1

0.58

4.81

u/ml

3.06

299

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.91

0.10

1.0

0.17

0.48

u/ml

—

(3029612) Listeria sp Ab [Titer] in Serum

1.12

0.09

1.4

1.3

—

(3040794) Aluminum [Moles/volume] in Urine

0.80

0.08

1.0

1.3

0.25

0.28

umol/l

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

125

669

0.98

0.08

1.1

1.2

4.91

9.10

u/ml

0.59

456

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

256

0.96

0.07

1.0

1.1

0.30

0.50

u/ml

0.20

256

(3006462) Nitrate [Presence] in Urine

137

701

1.02

0.06

2.4

2.3

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.08

0.06

1.1

1.0

0.84

0.57

u/ml

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

257

1.04

0.06

1.0

1.1

3.93

10.25

u/ml

3.19

158

(4133840) Spirometry

106

542

1.02

0.05

1.2

1.1

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.93

0.05

1.0

0.30

1.18

u/ml

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

372

0.98

0.02

1.0

1.1

0.17

4.14

u/ml

4.36

299

(40758292) HTLV I+II Ab panel - Serum

428

1.01

0.02

1.3

1.4

—

(40762814) Titanium [Mass/volume] in Blood

122

1.03

0.00

2.3

2.6

2.88

3.54

ug/l

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.07

0.00

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

406

1.00

0.00

1.1

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.93

-0.00

1.6

2.5

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint RX_ANTIHYP and mortality.

Females

Parameter	HR [95% CI]	p-value
RX_ANTIHYP	0.891 [0.84, 0.95]	< 0.001
Birth year	0.998 [0.99, 1.0]	0.496

During the follow-up period (1.1.1998 — 31.12.2019), 143742 out of 808782 females with RX_ANTIHYP died.

Males

Parameter	HR [95% CI]	p-value
RX_ANTIHYP	0.995 [0.93, 1.06]	0.886
Birth year	0.988 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 148263 out of 757662 males with RX_ANTIHYP died.

Mortality risk

Mortality risk for people of age

years, who have RX_ANTIHYP.

N-year risk	Females	Males
1	0.071%	0.14%
5	0.42%	0.87%
10	1.084%	2.296%
15	2.231%	4.492%
20	4.044%	7.782%

Relationships between endpoints

↥

Index endpoint: RX_ANTIHYP – Antihypertensive medication - note that there are other indications

GWS hits: 335

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Antihypertensive medication - note that there are other indications

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints